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INTRODUCTION 
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Dengue is the most rapidly spreading mosquito-borne viral disease in the world. 
During the last fifty years, incidence has risen to 30-fold with increasing geographic 
expansion to new countries and, in the present scenario, from urban to rural settings . 
An estimated 50 million dengue infections occur every year and approximately 2.5 
billion people are living in dengue endemic countries. The 2002 World Health Assembly 
resolution 55.17 urged greater commitment to dengue by WHO and its Member States. Of 
particular significance is the 2005 World Health Assembly resolution 58.3 on the revision of 
the International Health Regulations (IHR) , which includes dengue as an example of a 
disease that may cause a public health emergency of international concern with implications 
on health security due to disruption and rapid epidemic spread beyond national borders. 
Some 1.8 billion (more than 70%) of the population at risk for dengue worldwide live 
in member states of the WHO South-East Asia Region and Western Pacific Region, which 
bear nearly 75% of the current global disease burden due to dengue. The Asia Pacific Dengue 
Strategic Plan for both regions was been prepared in consultation with member countries and 
development partners in response to the increasing threat from dengue, which is spreading to 
new  geographical areas and causing high mortality during the early phase of outbreaks. The 
strategic plan aims to aid countries to reverse the rising trend of dengue by enhancing their 
preparedness to detect, characterize and contain outbreaks rapidly and to stop the spread to 
new areas. Since 2000, epidemic dengue has spread to new areas and has increased in the 
already affected areas of the region. In 2003, eight countries -- Bangladesh, India, Indonesia, 
Maldives, Myanmar, Sri Lanka, Thailand and Timor-Leste -- reported dengue cases. In India, 
changes in genotypes/lineages have been associated with increasing severity .  
Tirunelveli district (Tamilnadu) faced an epidemic in 2012 & 2013 at Kadayanallur 
and Ambasamudram blocks. Tirunelveli Medical College Hospital (TVMCH) is the only 
tertiary care centre in this district. Case Fatality Rate(CFR) was high during the initial phase 
of the epidemic. In January 2012 the CFR was 10.34%, considered to be higher than other 
 
 
2 
 
international reports. In spite of all the efforts, there was again an increase in CFR to 66.66% 
in July 2013. Deaths were alot due to Dengue Shock Syndrome with CNS and GIT 
complications. Approximately accounting to 22 Paediatric and 7 Adult deaths in positive 
dengue patients in 2012, and 6 Paediatric and 4 Adult deaths reported in 2013.In all these 
deaths patients arrived late to TVMCH after onset of major complications. Once epidemics 
subsided, the CFR was risen due to non sustenance of the intervention resulting in late 
referrals. A study was carried out on Analysis of Dengue Diagnostic Immunochromatography 
and ELISA in the year 2014. 
Dengue virus (DENV) is a positive-sense, single-stranded RNA virus in the family 
Flaviviridae that causes disease in human beings. DENV infection results in different clinical 
manifestations ranking from benign disease [dengue fever (DF)] to severe disease [dengue 
haemorrhagic fever (DHF)]. In situations where the onset of hypovolaemic shock or dengue 
shock syndrome (DSS) persists, DHF can result in a life-threatening infection. DHF is 
characterized by increased vascular permeability resulting in plasma leakage and coagulation 
derangements. DHF can be classified further into four degrees of severity, and degrees III and 
IV are considered to be DSS (WHO, 2005). Due to the lack of efficient biomarkers that 
define endothelial damage for determining the degree of severity, there is an urgent need to 
find relevant biological markers of disease, as well as to determine more coherent definitions 
of the degree of severity in patients. Many laboratories are thus combining in vitro studies 
with clinical studies to find correlates of pathogenesis and disease severity.  
Dengue has a wide spectrum of clinical presentations, often with unpredictable 
clinical evolution and outcome. While most patients recover following a self-limiting non-
severe clinical course, a small proportion progress to severe disease, mostly characterized by 
plasma leakage with or without haemorrhage.  
One of the pathophysiological hallmarks of severe dengue is increased vascular 
permeability, leading to a loss in blood volume that if uncorrected, could lead to shock. The 
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degree of plasma leakage varies and prediction of severe plasma leakage has been 
challenging. 
Daily or even more frequent monitoring of hematocrit levels may be required for 
atleast 2–3 days around the period of fever defervescence to detect plasma leakages on a first 
onset. As routine fluid support prevents progression of plasma leakage to hypovolemic shock 
and multi-organ failure, tools that enable triaging of patients according to disease outcome 
could enable a more effective use of limited healthcare resources, especially during dengue 
epidemics. Indeed, the components of early pathophysiological mechanisms could serve as 
reliable prognostic factors given their mechanistic role in disease manifestation. It is 
generally believed that the observed pathophysiology is immune-mediated brought about by 
monocytes, T-cells, endothelial cells, mast cells and increasingly platelets, as well as the 
interactions between these cell types. Despite the presence of thrombocytopenia in the acute 
stages of dengue, less work has been done on the pathologic contribution of platelet-derived 
soluble factors in DHF progression and their use as prognostic markers. Platelets circulate in 
high numbers throughout the system and upon activation release their granule contents to 
exert their haemostatic, immunological and inflammatory effects. DENV has been reported to 
activate platelets . 
 
Case definition: 
 Severe dengue – Dengue confirmed cases plus severe thrombocytopenia                
(<50,000 platelets/mm3) and/or hypotension (postural hypotension with decrease in 
systolic arterial pressure in 20 mm Hg in supine position or systolic arterial pressure  
< 90 mm Hg) and/or plasma leakage (either haemoconcentration fluctuation of packed 
cell volume ≥ 20% during illness course and recovery or clinical signs of plasma 
leakage, such as pleural effusion) and/or severe haemorrhagic manifestations. 
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 Mild dengue – Dengue confirmed cases in absence of severe thrombocytopenia, 
hypotension, plasma leakage signs or haemorrhagic manifestations. 
 
Viral and host factors can both contribute to disease severity.  
   
Epidemiologic data suggests that there is  a greater risk of DHF/DSS during 
secondary infections, and immunopathologic mechanisms, such as immune-enhancement 
phenomenon, have been proposed to contribute to DHF risk. This contribution occurs when 
non neutralizing antibodies resulting from the primary infection favour dissemination of the 
second infecting Dengue virus, a phenomenon known as antibody-dependent enhancement, 
and cross-reactive memory T cells from a primary infection recognize antigen from the 
secondary infection, resulting in increased T cell activation and cytokine production. 
Antibody enhancement, improper T cell and cytokine response and host genetic factors are 
amongst the postulated immunopathogenesis leading to severe dengue. 
Cytokines are important immunomodulators and improper T-cell activation can lead 
to cytokine storms which are believed to result in endothelial permeability and leakage, a 
typical feature of Dengue disease progressing into a more severe stage. Many cytokines have 
been implied in causing severe Dengue manifestations among which IL-10 poses to be an 
important one. Increased levels of serum IL-10 may be a useful prognostic hallmark in 
DHF/DSS patients. IL-10 is a cytokine with pleiotropic effects in immunoregulation and 
inflammation. Higher levels of IL-10 are detected in DHF/DSS patients compared with DF 
patients, and this trend is observed for infants, children, and adults. Studies show increased 
levels of IL-10 from the onset of fever to defervescence, and viremia primarily occurs during 
fever in Dengue patients. The relationship between IL-10 and viral replication is therefore 
speculated. Targeting IL-10 regulation and signalling pharmacologically using neutralizing 
antibodies, antagonists, and inhibitors may represent a viable therapeutic strategy for 
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preventing the progression of severe dengue diseases. It is believed that the critical point in 
Dengue physiopathology is the plasmatic leakage mediated by the host immunological 
response. 
  Soluble circulating immunological mediators are associated with disease severe 
outcomes as shock and haemorrhages. Among them inflammatory cytokines such as TNFα 
and IFNγ have been emphasized . Regulatory activities of the cytokines are probably crucial 
in controlling the inflammatory response during Dengue disease, which is necessary for the 
control of viral infection, and the balance among inflammatory/regulatory mediators could be 
related to recovery of most patients with a dengue secondary infection. 
  
Despite of the drastic increase in the Incidence and CFR of Dengue Fever in 
Tirunelveli, there is still paucity of data to understand its pathophysiology and the role of 
immunological markers in the same. Therefore, there is an urgent need to evaluate these. 
Moreover, early identification of the exact pathophysiological profile is of paramount 
importance as it greatly reduces morbidity and mortality especially in cases with 
complications. Hence to prevent deaths an effective Primary Health Care Level 
understanding of Dengue Fever, its diagnosis, complications and knowledge of early 
management and triaging is essential and for the same a correlation of Dengue pathogenesis 
with the various cytokines may prove helpful for better care and management of Dengue 
Cases. 
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HISTORY 
The origin of the word DENGUE has a lot of  theories from various schools of 
thoughts, but one theory is that it is derived from the Swahili phrase "Ka-dinga pepo", 
meaning "cramp-like seizure caused by an evil spirit". The Swahili word "dinga" has  its 
origin in the Spanish word "dengue" meaning fastidious or careful, which would describe the 
gait of a person suffering the bone pain of dengue fever. The use of the Spanish word may 
derive from the similar-sounding Swahili. Slaves in the West Indies who contracted dengue 
were said to have the posture and gait of a dandy, and the disease was known as "Dandy 
Fever". 
The first record of a case of  dengue fever was in a Chinese medical encyclopedia 
from the Jin Dynasty (265–420 AD) which referred to a “water poison” associated with 
flying insects. The first recognized Dengue epidemics occurred almost simultaneously in 
Asia, Africa, and North America in the 1780s, shortly after the identification and naming of 
the disease in 1779. The first confirmed case report is from 1789  by Benjamin Rush, who 
coined the term "breakbone fever" because of the symptoms of myalgia and arthralgia. 
The viral etiology and the transmission by mosquitoes were only deciphered in the 
20th century. The socioeconomic impact of World War II resulted in increased spread 
globally. 
DF had a world wide distribution by the late 18th century, with nearly simultaneous 
epidemics that occurred in 1779 in Batavia (Jakarta), Indonesia, and Cairo, Egypt, and in 
1780 in Philadelphia, Pennsylvania . Epidemics of DF were common during the 18th and 
19th centuries in the Americas, the Caribbean, Asia, Australia, and the Pacific. Outbreaks of 
an illness in the French West Indies in 1635 and in Panama in 1699 may have been dengue . 
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DENV Transmission by the Aedes aegypti was first described by Bancroft  and later 
confirmed by Cleland et al. . Ashburn and Craig found a filterable, infectious agent in human 
blood. Siler et al.  and Simmons et al. performed an experiment where they transmitted the 
virus to human volunteers and established the incubation period in mosquitoes. DENV was 
isolated in mice by Kimura and Hotta in 1943 and by Sabin and Schlesinger in 1944 ; and the 
existence of more than one serotype (DENV-1 and -2) was established by HI test and cross-
protection studies in human volunteers. DENV-3 and -4 were isolated during epidemics in the 
Philippines in 1956 . 
The ecologic amendments and massive human movement during World War II, and 
the economic development, population growth, and uncontrolled urbanization that followed, 
all contributed to the increased incidence and emergence of epidemic DHF in the 1950s and 
1960s in Southeast Asia . The numbers of countries and human populations affected have 
gradually increased and, today, dengue is considered a serious, global public health problem; 
epidemics involving thousands of people and multiple virus serotypes recur in areas of 
tropical Asia, Oceania, Africa, and the Americas. Since the 1980s, DF and DHF, described 
for the first time in 1953 , have come out as the most important arthropodborne viral disease 
of humans .  
More than 2.5 billion people live in areas of risk for DENV infection; and 100 million 
infections and 250,000 to 500,000 cases of DHF occur annually with an average DHF case 
fatality rate of 5%. 
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Etiologic Agents 
Group: Group IV ((+)ssRNA) 
Order: Unassigned 
Family: Flaviviridae 
Genus: Flavivirus  
Species: Dengue virus 
 
Four virus serotypes (DENV-1, -2, -3, and -4) have been recognized and constitute a 
distinct antigenic complex . DENV-1 and DENV-3 form a subcomplex defined by MAbs and 
polyclonal antibodies . Some antigenic heterogeneity occurs among strains of each serotype 
by conventional Nt . However, MAbs have also shown antigenic relationships at the 
subcomplex level (e.g., between DENV-1 and -3, DENV-2 and -4, and between DENV and 
JE and TBE complex viruses) .  
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NS1 protein 
Flavivirus NS1 is a  48-kDa glycoprotein that is translocated into the ER lumen co-
translationally. Within the ER, NS1 promptly dimerizes upon addition of high-mannose 
carbohydrates  and is targeted to three destinations: the viral replication sites, the plasma 
membrane and the extracellular compartment. The majority of the NS1 secreted is a soluble, 
proteolipid particle forming an open-barrel hexameric shell with a central channel occupied 
by lipids . The 3D high-resolution structure of the DENV NS1 dimer has been recently solved 
by X-ray crystallography , providing valuable insights into the complex NS1 fold . The dimer 
contains three domains: first, a small β-roll domain formed by two intertwined β-hairpins; 
second, a Wing domain, composed of an α/β subdomain and a discontinuous connector that 
sits against the β-roll; third, a β-ladder domain, formed by 18 antiparallel β-strands (9 
contributed by each monomer) assembled in a continuous β-sheet that runs along the whole 
length of the dimer . 
E protein 
The DENV E (envelope) protein, is a dimer on the surface of the mature viral particle, 
is important in the initial attachment of this particle to the host cell. Each E protein monomer 
comprises three ectodomains, ED1 to ED3, and a trans-membrane segment. ED2 contains the 
dimerization interface, two glycosylation sites, and the peptide of fusion with the cellular 
membrane. ED3 is a continuous polypeptide segment; its fold is compact and antibody-like.  
prM/M protein 
The DENV prM (membrane) protein, is important in the formation and maturation of 
the viral particle, and it contains of seven antiparallel β-strands stabilized by three disulfide 
bonds. 
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NS3 protein 
The DENV NS3 is a serine protease, and an RNA helicase and RTPase/NTPase. The 
protease domain consists of six β-strands arranged into two β-barrels formed by residues 1–
180 of the protein.  
NS4A protein 
DENV NS4A is a non-structural protein that is involved in altering cell membrane 
curvature and induction of autophagy.  
 
NS5 protein 
The DENV NS5 protein is a 900 residue peptide containing a methyltransferase 
domain at its N-terminal end (residues 1–296) and a RNA-dependent RNA polymerase 
(RdRp) at its   C-terminal end (residues 320–900).  
Complexes between the E protein and neutralizing antibodies 
Crystal structures of complexes between antibodies and either the ectodomain (sE) of 
the viral E protein or its domain 3 (ED3) have helped infer the molecular bases of the virus 
recognition and neutralization. Some of the epitopes are partially or totally inaccessible in the 
known structure of the mature virion. The corresponding immunoglobulins are therefore 
assumed to bind to alternate or transitional conformations of the virus at 37 °C. 
Viral replication 
Flaviviruses have a (+) sense RNA genome and replicate in the cytoplasm of the host 
cells. The genome resembles the cellular mRNA molecule in all aspects except for the 
absence of the poly-adenylated (poly-A) tail. This feature permits the virus to exploit cellular 
apparatus to synthesise both structural and non-structural proteins, during replication. The 
cellular ribosome is crucial to the replication of the flavivirus, as it translates the RNA, in a 
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similar fashion to cellular mRNA, resulting in the production of a single polyprotein. In 
general, the genome encodes 3 structural proteins (Capsid, prM, and Envelope) and 7 non-
structural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B, NS5) The genomic RNA is 
altered at the 5′ end of positive-strand genomic RNA with a cap-1 structure (me7-GpppA-
me2). 
Cellular RNA cap structures are synthesised via the action of an RNA triphosphatase, 
with guanylyltransferase, N7-methyltransferase and 2′-O methyltransferase. The virus 
encodes these activities in its non-structural proteins. The NS3 protein encodes a RNA 
triphosphatase inside its helicase domain. It uses the helicase ATP hydrolysis site to remove 
the γ-phosphate from the 5′ end of the RNA. The N-terminal domain of the non-structural 
protein 5 (NS5) has both the N7-methyltransferase and guanylyltransferase activities 
important for forming mature RNA cap structures. RNA binding affinity is decreased by the 
presence of ATP or GTP and enhanced by S-adenosyl methionine. This protein also encodes 
a 2′-O methyltransferase. 
Once translated, the polyprotein is cleaved by a combination of viral and host 
proteases to release mature polypeptide products. Nevertheless, cellular post-translational 
modification is dependent on the presence of a poly-A tail; therefore this process is not host-
dependent. Instead, the polyprotein contains an autocatalytic feature which automatically 
releases the first peptide, a virus specific enzyme. This enzyme is then able to cleave the rest 
of the  polyprotein into the individual products. One of the products cleaved is a polymerase, 
responsible for the synthesis of a (-) sense RNA molecule. Sequentially , this molecule acts as 
the template for the synthesis of the genomic progeny RNA. 
Flavivirus genomic RNA replication takes place on rough endoplasmic reticulum 
membranes in membranous compartments. 
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New viral particles are subsequently assembled. This happens during the budding 
process which is also responsible for the accumulation of the envelope and cell lysis. 
A G protein-coupled receptor kinase 2 (also known as ADRBK1) is important in entry 
and replication for several Flaviviridae. Haderson et al. 
 
HOSTS 
DENVs grow  varied  primary and continuous cell cultures; high viral yield and CPE 
are difficult to obtain in many vertebrate cell systems without adaptation.  
The initial target cells for DENV infection in humans are dendritic cells. Studies of human 
skin explants and skin biopsies have demonstrated that 60% to 80% of local dendritic cells 
expressed DENV antigens . DENV has been isolated from   human liver, lung, spleen, lymph 
node, thymus, kidney, skin, mononuclear phagocytes, brain, and endothelium . Skin lesions 
show swelling of small vessel endothelial cells, perivascular edema, and infiltration of 
mononuclear cells. 
 
Vectors 
There are two major groups of arthropod vectors of flaviviruses, ticks and mosquitoes. 
The latter are by far the most important as vectors of human and domestic animal infections, 
with each group of viruses having a rather unique group of mosquito vectors. The DENV 
complex , which have primates as their natural vertebrate hosts, have Aedes species 
mosquitoes as their natural vectors. The ability of arthropod vectors to transmit flaviviruses 
depends on intrinsic and extrinsic factors . The most important intrinsic factors for 
mosquitoes are genetic variabilities among the vectors and the viruses . Oral susceptibility to 
infection in mosquitoes can be increased or decreased by genetic selection. Similarly, strains 
of the same virus species exhibit variable infectivity for the same mosquito population.  
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 Steps required for flaviviruses infection and transmission by a mosquito.  
 
Epidemiology 
 
DENVs are maintained in forest cycles in lower primates and canopy-dwelling Aedes 
mosquitoes.DENVs, however, are the only arboviruses that have adapted to humans and the 
domestic environment to the point where the forest cycle is not required anymore for 
maintenance. The principal transmission cycle of DENVs thus involves only humans and 
mosquitoes in large tropical urban centers. Aedes aegypti is the most important vector, but 
secondary mosquito vectors include Aedes albopictus and Aedes polynesiensis. Dengue 
occurs principally in tropical areas of Asia, Oceania Africa, and the Americas. Subtropical 
and temperate areas are susceptible to hot weather introduction and spread of the virus. Since 
the mid-1990s, dengue has spread as far south as Argentina, and small outbreaks occurred on 
Easter Island and Hawaii in the Pacific and in Nepal. Dengue outbreaks have also occurred at 
high altitude in Mexico . 
In tropical urban areas infested with Ae. aegypti and/or Ae. albopictus, one or more 
DENV serotypes are usually maintained endemically. Elsewhere, epidemics result from the 
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introduction of a new serotype . The asymptomatic-to-symptomatic ratio in dengue varies 
with virus strain, age, and immune status of the population. In some situations, dengue 
infections present as mild or subclinical illness; as a result, many cases are unnoticed. In 
other situations, epidemics may be explosive with high rates of symptomatic infection and 
severe disease . Changes in the environment, in the human, mosquito, and virus populations, 
can result in hiekes transmission and epidemics . Therefore, a long-term, active, laboratory-
based surveillance system is needed to find the risk for epidemic DF. 
 
           The viruses have enzootic maintenance cycles involving tree-hole breeding mosquito 
vectors and nonhuman primates. Dengue viruses are transmitted principally between humans 
and Aedes aegypti that breed in domestic and peridomestic water containers in urban areas. A 
sylvatic cycle has been documented in Southeast Asia and West Africa, but it is presently 
uncertain to what extent this cycle contributes to human infections.  
 
Protection against homotypic reinfection is complete and probably life long, but 
cross-protection between DENV serotypes lasts less than 12 weeks . Consequently, it is 
possible to sustain  dengue infections. In general, clinically overt illness with viremia occurs 
during primary or secondary infections . 
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Transmission cycles of dengue viruses 
 
Clinical Features 
 
Infection with DENVs causes a spectrum of illness ranging from inapparent or mild 
viral syndrome to classic DF and severe hemorrhagic disease. All four virus serotypes cause 
similar illness, but severe and fatal hemorrhagic disease is more often associated with DENV-
2 and -3 infections . 
 
Dengue Fever 
 
The clinical manifestations of DF were described by Siler et al., Simon et al. , and 
Sabin . Typically, the disease begins abruptly, after a 2- to 14-day (mean 4 to7 days) 
incubation period, with high fever, headache, retroocular pain, lumbosacral pain, conjunctival 
congestion, and/or facial flushing. Fever may last only 1 to 2 days, may persist for 6 to 7 
days, or may have a biphasic course. Initial symptoms are followed by generalized myalgias 
or arthralgias that increase in severity, anorexia, nausea, vomiting, weakness, and prostration. 
The pulse rate may be slow in relation to the fever. Respiratory symptoms (cough, sore 
 
 
17 
 
throat, and rhinitis) are not uncommon but is most commonly caused by concurrent infection 
with other viruses or bacteria, especially in children. A transient, generalized macular or 
mottled rash appears on the first or second day. Coincident with defervescence or shortly 
after that, a secondary rash, maculopapular or morbilliform and nonirritating, appears first on 
the trunk and then spreads centripetally to the face and limbs but spares the soles and palms. 
The rash may subside. Fever may rise again, creating the second phase of a saddleback 
course. Generalized lymphadenopathy, cutaneous hyperesthesia, and altered (metallic) taste 
sensation may accompany this stage of the disease. The peripheral white blood cell count is 
decreased with an absolute granulocytopenia, and the platelet count may fall to less than 
100,000 per mm3. Hemorrhagic phenomena may lead to petechiae, epistaxis, intestinal 
bleeding, menorrhagia, and a positive tourniquet test. Myocarditis and various neurologic 
disorders, including encephalopathy and peripheral mononeuropathy, polyneuritis, and Bell's 
palsy, have been associated with DF . CNS disorders are  more common in DHF than in 
classic dengue. Development of Reye syndrome has been reported in some dengue infections. 
Convalescence may be prolonged, with generalized weakness, depression, bradycardia, and 
ventricular extrasystoles. 
Dengue Hemorrhagic Fever and Dengue Shock Syndrome 
 
Apart from  classic DF, infections with DENVs can cause a range of severe disease, 
including fulminant hepatitis with massive hemorrhage, organ failure, vascular leak with 
hypovolemia, cardiomyopathy, and encephalopathy. The most common severe manifestation 
of dengue is a vascular leak syndrome known as DHF. Onset of DHF is generally sudden, 
with fever of 2 to 7 days duration and varied nonspecific signs and symptoms. 
Hemorrhagic manifestations are common. Scattered petechiae are common and 
appear commonly on the extremities, as well as on the trunk and face in severe cases of DSS. 
Purpuric lesions are most common at the site of venipuncture. More sick patients have 
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gastrointestinal hemorrhage. Classic hematemesis and melena usually occur after prolonged 
shock, but upper gastrointestinal hemorrhage may lead to before the onset of shock . Most 
commonly, shock is caused by plasma leakage, which may be mild and transient or may 
progress to profound shock . Children with shock are often somnolent, exhibit petechiae on 
the face, and have perioral cyanosis. 
DHF is classified into four grades of illness based on severity. Grade I is not severre; 
the only hemorrhagic manifestations are scattered petechiae or a positive tourniquet test. 
Grade II is more severe with one or more overt hemorrhagic manifestations. Grade III is 
characterized by mild shock with signs of circulatory failure; the patient may be tired or 
restless and have cold extremities, clammy skin, a rapid but weak pulse, narrowing of pulse 
pressure or hypotension. Grade IV, the most severe form of DSS, is characterized by 
profound shock with undetectable pulse and blood pressure. 
Many patients with severe dengue disease do not fit in the previous classification of 
DHF/DSS . In a study in Indonesia, only 63% of 30 virologically confirmed fatal cases met 
the World Health Organization (WHO) case definition for DHF. Shock due to massive 
bleeding and encephalopathy were responsible for the rest. This has resulted in a call to 
change the WHO case definition to make it more inclusive of the broad spectrum of severe 
disease caused by DENV infection . In severe cases of DHF and DSS, fever and nonspecific 
signs and symptoms of a few days duration are followed by sudden deterioration of the 
patient's condition. During, shortly before, or after the fall in temperature, the patient's skin 
may become cool, blotchy, and congested; circumoral cyanosis is frequently observed, and 
the pulse becomes rapid and weak. Although some patients appear lethargic at first, they 
become restless and then rapidly pass into a critical stage of shock. They frequently 
experience acute abdominal pain shortly before the onset of shock . 
In mild cases of DHF, all signs and symptoms abate shortly after the fever comes 
down. Defervescence may be accompanied by excessive sweating, mild changes in pulse rate 
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and blood pressure, coolness of extremities, and skin congestion reflecting transient 
circulatory disturbances as a result of plasma leakage. Patients in shock are in danger of 
dying without appropriate therapeutic management. The duration of shock is usually short; 
the patient may die within 8 to 24 hours or recover rapidly following therapy. Convalescence 
for patients with DHF, with or without shock, is usually short and uneventful. Even in 
patients with undetectable pulse and blood pressure, once the shock is overcome, recovery 
usually occurs within 2 to 3 days without sequelae. 
As with DF, leukopenia is not uncommon. Thrombocytopenia and hemoconcentration 
indicating plasma leakage are constant findings in DHF and DSS. A platelet count of less 
than 100,000 per mm3 is usually found within the third and eighth day of illness. 
Hepatomegaly is common, but not a constant finding. In some countries, most patients with 
confirmed DHF or DSS have hepatomegaly, whereas in others hepatomegaly varies from one 
epidemic to another, suggesting that the strain or serotype of virus may influence liver 
involvement. Elevated liver enzymes are common. 
The primary pathophysiological abnormality is an acute increase in vascular 
permeability that causes leakage of plasma into the extravascular compartment, resulting in 
hemoconcentration and decreased blood pressure. Plasma volume is reduced more than 20% 
in severe cases. Supporting evidence of plasma leakage includes serous effusion found 
postmortem, pleural effusion on radiograph, hemoconcentration, and hypoproteinemia. No 
destructive vascular lesions have been observed, suggesting that the transient functional 
vascular changes are due to a short-acting chemical mediator. However, extensive 
postmortem studies have not been conducted. 
Hemostatic alterations in DHF and DSS involve three factors: vascular changes, 
thrombocytopenia, and coagulation disorders. Almost all DHF patients have increased 
vascular permeability  and thrombocytopenia, and many have abnormal clotting factor 
counts, suggesting disseminated intravascular coagulation, which is also evidenced by 
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concomitant thrombocytopenia, prolonged partial thromboplastin time, decreased fibrinogen 
level, and increased fibrin degradation products. Gastrointestinal hemorrhage is found at 
autopsy in the majority of patients. 
 
Differential Diagnosis 
Residence or recent travel to dengue endemic areas and occurrence of similar cases in 
the community are important clues to the diagnosis. Other infections that may be clinically 
confused with dengue include influenza, measles, rubella, malaria, scrub typhus, 
leptospirosis, other viral hemorrhagic fevers, and arboviral and rickettsial infections. Rash is 
a helpful feature, but it may be difficult to differentiated in dark-skinned patients. Other 
arbovirus infections that may be accompanied by rash and resemble DF include chikungunya, 
Onyong nyong, Sindbis, Mayaro, Ross River, and WN viruses. 
Anushya Rathakrishnan et al. Generally, participants sought medical intervention 
during the 5th DOI, with the admission average also at 5th DOI. The clinical symptoms of the 
dengue suspected patients in general included vomiting (59.1%), myalgia (56.3%), arthralgia 
(49.8%), diarrhea (45.4%), various cerebral symptoms including headaches, and retro-orbital 
pain (30.0%) nausea (28.4%), rashes (10.3%) and petechia (0.8%) . The warning signs in 
patients included a concurrent increase in hematocrit with the decrease of platelets, 
abdominal pain and tenderness (52.0%), bleeding tendencies (17.1%), postural giddiness 
(24.4%), hepatomegaly and tenderness (22.6%), splenomegaly (0.8%), pleural effusion 
(1.4%) and ascites (0.4%). An overwhelming 42.9% of recruited patients were also diagnosed 
with acute hepatitis . 
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Average annual number of dengue fever/dengue hemorrhagic fever cases reported to the 
World Health Organizaiton by decade from 1955 to 2005. (Courtesy of the World Health 
Organization.) The reported cases represent only the tip of the iceberg. 
 
 
Present scenario of Dengue Diagnosis 
 
Shrivastava et al. At present, the three basic methods used by most laboratories for the 
diagnosis of dengue virus infection are viral isolation; detection of viral genomic sequence by 
a nucleic acid amplification technology assay (RT-PCR), and detection of dengue virus-
specific IgM antibodies by the IgM-capture enzyme-linked immunosorbent assay  and/or the 
rapid dengue immunochromatographic test (ICT).  
Alcon C et al. Though virus isolation and characterisation are considered as the gold 
standard of laboratory diagnosis for acute dengue virus infection, it is expensive and takes at 
least 6–10 days for the virus to replicate in cell culture or laboratory mosquitoes. Detection of 
viral genomic sequence by RT-PCR is also an expensive method and is not widely available 
in most hospital diagnostic laboratories. The third method, assay of antidengue-specific IgM, 
depends on the time taken for an infected person’s immunological response to produce IgM 
antibodies against dengue virus antigens. Thus, both ICT (often considered as the rapid test 
for diagnosis of dengue infection) and MAC-ELISA do not provide early diagnosis of acute 
dengue infection, as in most cases, the first detectable IgM only appears on days 4–5 of the 
illness.  
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Das D et al. a single serological detection of IgM is merely indicative of a recent 
dengue virus infection, and should not be interpreted as a confirmatory diagnosis of acute 
infection without a paired second serum sample. The reason behind the less number of virus 
isolates could be the inactivation of the virus during transit due to improper maintenance of 
strict cold chain. NS1 protein was found to be highly conserved for all dengue serotypes, 
circulating in high levels during the first few days of illness, and correlates with the 
development of DHF. Earlier studies found the presence of NS1 antigen in 82–83% of 
patients with dengue infection from day 1 up to day 9 to 18 after the onset of fever. The 
dengue NS1 antigen was not found in patients with Japanese encephalitis virus or yellow 
fever virus infections thereby implying that there is no cross-reaction of dengue NS1 protein 
with those of other related flaviviruses.  
Thus detection of NS1 has been a promising test to diagnose dengue in its early 
febrile stage. 
Lapphra K et al. stated that Plasma viremia levels would be associated with the 
detection of plasma NS1, since NS1, like virions, is a product of infected cells. Accordingly, 
viremia levels were significantly higher in patients who were NS1-positive at the time of 
study enrolment versus those who were NS1negative. Firstly, not every acute dengue case 
has measurable NS1 antigenaemia and the present study suggests that this is a reflection of 
the viraemia, with NS1-negative patients having a significantly lower mean viraemia than 
NS1-positive patients with the same duration of illness history. Secondly, sensitivity declines 
with increasing time since the onset of symptoms and this is likely a reflection of decreasing 
viral burden. A possible explanation for reduced NS1 sensitivity in the presence of a 
measurable anti-DENV antibody response is that the plasma NS1 is sequestered in immune 
complexes and the target epitopes are not accessible to either the platebound or probe mAb in 
the NS1 ELISA.  
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Shrivastava et al. Indeed, efforts to dissociate immune complexes can enhance the 
sensitivity of the early ELISA assay. They may already have an established anamnestic 
humoral immune response characteristic of a secondary infection and are therefore more 
likely to be NS1-negative. It is therefore imperative that clinicians and laboratorians should 
understand the limitations of existing NS1 antigen tests; that a NS1negative result does not 
rule out the diagnosis of dengue.  
  NS1 antigen test is a potentially useful test during early febrile stage. An outstanding 
point of the test is its high specificity during early infection. However, no single diagnostic 
assay in isolation is adequately sensitive and specific enough to diagnose all acute cases of 
dengue and therefore a battery of tests has to be performed to arrive at a confirmatory 
diagnosis of dengue infection. 
Cytokines in Dengue Prognosis 
 
All four DENV serotypes (1–4) cause DF or DHF/DSS (Monath, 1994). Secondary 
infection with a serotype different from the first infection is a risk factor for developing 
DHF/DSS (Guzma ´n et al., 1991; Halstead, 1981). Cells carrying the FccRII receptor, such 
as monocytes, macrophages and platelets, can also opsonize DENV with non-neutralizing 
heterotypic antibodies from the first infection. This may lead to an increase in the number of 
circulating viruses and activation of monocytes and T cells that secrete disproportionate 
amounts of cytokines inducing plasma leakage (Kurane, 2007). A series of cytokines – 
tumour necrosis factor alpha (TNF-a), gamma interferon (IFN-c), interleukin (IL)-6, IL-8 and 
IL-10 – have been shown to correlate with the severity of dengue infection (Bozza et al., 
2008; Chakravarti & Kumaria, 2006; Chen et al., 2006; Raghupathy et al., 1998). Low-
avidity T cells cross-reactive to different serotypes may predominate over antigen-specific T 
cells, thus resulting in an inadequate response to the virus and uncontrolled cytokine 
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production (Mongkolsapaya et al., 2003, 2006). The DHF/ DSS pathogenesis model indicates 
that the disease results from an altered immune reaction in patients. 
The signal transduction pathways activated by the proinflammatory cytokine 
interleukin-1 (IL-1) have been the focus of much attention because of the important role that 
IL-1 plays in inflammatory diseases. A number of proteins have been described that 
participate in the post-receptor activation of the transcription factor nuclear factor kappaB 
(NF-kappaB), and stress-activated protein kinases such as p38 mitogen-activated protein 
kinase (MAPK). It has also emerged that the type I IL-1 receptor (IL-1RI) is a member of an 
expanding receptor superfamily. These related receptors all have sequence similarity in their 
cytosolic regions. The family includes the Drosophila melanogaster protein Toll, the IL-18 
receptor (IL-18R), and 10 Toll-like receptors (TLRs), TLR-1 to TLR-10, which bind to 
microbial products, activating host defense responses. Because of the similarity of IL-1RI to 
Toll, the conserved sequence in the cytosolic region of these proteins has been termed the 
Toll-IL-1 receptor (TIR) domain. The same proteins activated during signaling by IL-1RI 
also participate in signaling by other receptors with TIR domains. The receptor superfamily is 
evolutionarily conserved; members also occur in plants and insects, where they also function 
in host defense. The signaling proteins that are activated are also conserved across species. 
Differences are, however, starting to emerge in signaling pathways activated by different 
receptors. This receptor superfamily, therefore, represents an ancient signaling system that is 
a critical determinant of the innate immune and inflammatory responses.The interleukin-1 
receptor-like-1 protein (IL1RL1), also known as ST2, is a member of the IL1R/Toll-like 
receptor (TLR) superfamily (Dunne & O’Neill, 2003). The ST2 gene (also designated T1 or 
DER4) was originally identified as a gene induced by oncogene expression in mouse 
fibroblasts (Tominaga, 1989). Three isoforms are generated from alternative mRNA splicing: 
a membrane-anchored long form (ST2L), a secreted soluble form (sST2) and a membrane-
anchored variant form (ST2V) (Bergers et al., 1994; Iwahana et al., 1999). It has been 
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postulated that both ST2L and sST2 are involved in the control of cytokine expression during 
inflammatory events to regulate exacerbated inflammatory responses (Trajkovic et al., 2004). 
Transient ST2L expression in human and mouse cells does not activate NF-kB (Brint et al., 
2002), but it has been reported that ST2L blocks this signalling route, probably by 
sequestration of the MyD88 and Mal adaptor proteins, which are downstream of IL1RL1 and 
TLR signalling, respectively (Brint et al., 2004). ST2L is considered to be a marker for the 
activated T helper 2 (Th2) lymphocyte subpopulation (Lo ¨hning et al., 1998) and could be 
involved in binding of the Th2 effector cell to the ligand IL-33 (Schmitz et al., 2005). In 
contrast, sST2 expression occurs in response to increased pro-inflammatory cytokines in 
mouse fibroblasts and human umbilical vein endothelial cells (HUVECs) (Kumar et al., 
1997). sST2 inhibits TNF-a, IL-6, IL-12 and IL-1a production in different in vivo and in vitro 
models of sterile inflammation (ischaemia model) or infectious inflammation [Escherichia 
coli lipopolysaccharide (LPS) stimulus or respiratory syncytial virus infection] (Fagundes et 
al., 2007; Sweet et al., 2001; Takezako et al., 2006; Walzl et al., 2001; Yin et al., 2006). sST2 
reduces TLR-4 expression and IkB degradation after LPS stimulation of macrophages and 
monocytes (Sweet et al., 2001; Takezako et al., 2006). Higher levels of sST2 have been found 
in patients having inflammatory disorders such as asthma (Oshikawa et al., 2001), 
autoimmune diseases (Kuroiwa et al., 2001), idiopathic pulmonary fibrosis (Tajima et al., 
2003), sepsis (Brunner et al., 2004) and myocardial infarction (Shimpo et al., 2004). 
Recently, increased serum sST2 was found in patients having secondary infection and DF, 
indicating its participation in the disease immunopathology (Becerra et al., 2008). 
An association between sST2 and the severity of DENV infection has not been 
determined. The cell type that expresses sST2 during DENV infection as well as the 
regulation of this process and its role during infection remain unknown. In the present study, 
we found that DHF patients had higher levels of sST2, TNF-a, IL-8 and IL-10 compared with 
DF patients and healthy controls. There were no detectable changes in the mRNA expression 
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of sST2 and ST2L in peripheral blood mononuclear cells (PBMCs). Stimulation of HUVECs 
with sera from DHF patients induced sST2 but not ST2L mRNA expression; in addition, the 
amount of secreted sST2 increased. The stimulation of sST2 was dependent on TNF-a. We 
hypothesize that the increase in sST2 from HUVECs is due to increased inflammation in 
vivo. sST2 could have predictive value as a marker of severity of disease. Prospective clinical 
samples can be used to test this hypothesis in the futureClinical studies support a key role for 
cytokines in the DHF pathogenesis. Secondary infection with a serotype different from the 
first infection is a risk factor for developing DHF/DSS (Guzma ´n et al., 1991; Halstead, 
1981). Cells carrying the FccRII receptor, such as monocytes, macrophages and platelets, can 
also opsonize DENV with non-neutralizing heterotypic antibodies from the first infection. 
This may lead to an increase in the number of circulating viruses and activation of monocytes 
and T cells that secrete disproportionate amounts of cytokines. inducing plasma leakage 
(Kurane, 2007). A series of cytokines – tumour necrosis factor alpha (TNF-a), gamma 
interferon (IFN-gamma), interleukin (IL)-6, IL-8 and IL-10 – have been shown to correlate 
with the severity of dengue infection (Bozza et al., 2008; Chakravarti & Kumaria, 2006; 
Chen et al., 2006; Raghupathy et al., 1998). Low-avidity T cells cross-reactive to different 
serotypes may predominate over antigen-specific T cells, thus resulting in an inadequate 
response to the virus and uncontrolled cytokine production (Mongkolsapaya et al., 2003, 
2006). The DHF/ DSS pathogenesis model indicates that the disease results from an altered 
immune reaction in patients. 
Cocila et al carried out a study on regulatory T cells stating that the host factors 
include parameters of the immune response and the genetic constitution. High levels of pro-
inflammatory, vasoactive cytokines and chemokines viz. IL-1, IL-6, IL-8, IL-10, IL-13, TNF-
α, NO, VEGF, MCP-1 and complement components such as C3a, C4b, C5a have been 
associated with moderate or dengue haemorrhagic fever (DHF)/dengue shock syndrome 
(DSS) cases . We have also reported similar associations of DHF with IL-6 and IL-8 
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(Priyadarshini et al.). Association of polymorphisms in several immune response-related 
genes, e.g. TNF-α, IL-1 β, IL-10, IL-17 F, FcγRII, CTLA-4, TGF-β1, HPA, DC-SIGN, TAP 
and JAK1, with disease severity has been reported by several groups, (Harapan H ; Alagaru 
K. et al.). 
Himanshu et al. Altered Tcell (CD3+, CD4 + and CD8+) frequencies in dengue 
infections 
T cell subset frequencies were compared in 42 mild cases, 34 moderate cases and 19 
controls. The frequency of total Tcells (CD3+)was lower in moderate cases (54.9%±2.7) 
compared to controls (62 %±2.3) (p=0.023) and mild cases (62.3 %±2) (p=0.024).CD8+ T 
cell frequencies were elevated in mild cases (25.8 %±1.4) compared to controls (21.4±1.3) 
(p=0.024). CD4+ T cell frequencies were comparable among the study subjects. When T cell 
frequencies were analysed in the context of time of sampling, Tcells were found to be 
elevated in mild cases (n=13) (60.5%±3.7) compared to moderate cases (n=9) (48.8%±5) in 
the pre-defervescence phase (p=0.043) but were comparable in the post-defervescence phase. 
In the context of immune status, T cell frequencies were elevated in primary cases (n=21) (64 
%±2.6) compared to secondary cases (n=52) (57.1 %±2.2) (p=0.038). Similarly, elevation in 
CD4+Tcell frequencies was observed in primary cases (32.1 % ± 2.1) compared to secondary 
cases (26.5 %±1.6) (p=0.042) , especially in primary moderate cases (n=6) (34.5 %±3.7) 
compared to secondary moderate cases (n=27) (24.1±2.1) (p=0.035) (Fig. 3b). CD4:CD8 
ratios were lower in total dengue cases (n=76) (1.3) compared to controls (n=19) (1.7) 
(p=0.045) and higher during the post-defervescence phase (n=20) (1.4) compared to the pre-
defervescence phase of moderate cases (n=9) (0.97) ( p=0.039). 
Higher cytokine/chemokine levels in moderate dengue 
The levels of IFN-γ, IL-7, IL-8, IL-10 and TNFα were significantly elevated in 
dengue cases (n=51) compared to controls (n=8) (p<0.05). IL-6, IL-8, IL-10 and TNF-α were 
significantly elevated in moderate cases (n=20) compared to mild cases (n=29), especially 
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evident during the post-defervescence phase (mild cases n=18 and moderate cases n=12) 
(p<0.05). The level of IL-7 was significantly elevated in moderate cases (n=7) compared to 
mild cases ( n=11) in the predefervescence phase (p=0.02) (Fig. 4a). The IFN-γ levels were 
increased in primary infections (n=15) (p=0.061), whereas the levels of IL-8 and MCP-1 
were increased in secondary infections (n=32) (p<0.05) . There was no significant difference 
in the cytokine levels between primary mild and moderate cases. The levels of IL-12p70, IL-
6, IL-8, IL-10, TNF-α were elevated in moderate cases (n=16) compared to mild cases (n=16) 
in secondary infections (p<0.05). 
Himanshu et al.Association of higher Treg frequencies with mild disease, irrespective 
of the time of sampling/immune status suggests a prognostic value for Tregs. Elevated Treg 
frequencies in the pre as well as post-defervescence periods in mild disease suggests a 
protective role for Tregs, which is further strengthened by the positive correlation of Treg 
frequencies with platelet tcounts. This finding is noteworthy, since thrombocytopaenia is one 
of the features of severe dengue. Platelet damage is caused due to anti-plateletantibodies, as 
well as DENV infection of megakaryocytes. Tregs have been shown to suppress the 
production of auto antibodies and, therefore, could also suppress the production of anti-
platelet antibodies in dengue patients. CD4+CD25−Foxp3+ T cells are, as yet, insufficiently 
characterised, and there are contradictory conclusions regarding their suppressive phenotype. 
Most of these studies include autoimmune disorders, with viral infections being poorly 
represented. In this study, the similar profiles observed for these cells and Tregs indicate a 
suppressive role for this population in dengue. The lower T cell frequencies observed in 
moderate cases during the pre-defervescence period and in secondary infections could be a 
result of the generalised bone marrow suppression reported in dengue infections. On the other 
hand, higher T cell frequencies observed in mild cases in the pre-defervescence period could 
be beneficial towards the outcome. Higher frequencies of CD8+ T cells in moderate cases 
may indicate an immunopathogenic role for this cell population, as suggested previously . 
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Higher levels of pro-inflammatory cytokines observed in our study have been well 
documented in dengue . The higher levels of IL-10 in moderate cases correlated negatively 
with platelet counts and had no correlation with Treg frequencies. Though Tregs are an 
important source of IL-10, monocytes are also known to secrete IL-10 through the intrinsic 
ADE pathway . 
 
It was also found that in moderate dengue, reduced Treg frequencies may result in 
unrestrained activation of immune cells and cytokine secretion, resulting in a tsunami of pro-
inflammatory cytokines, which, in turn, exerts an inhibitory influence on Tregs. A negative 
correlation of these pro-inflammatory cytokines observed during post-defervescence and in 
secondary infections implied that interplay between Tregs and pro-inflammatory cytokines 
during the latter half of the infection influences the disease outcome. 
Jamaluddin MS et al. The infection status (primary versus secondary infections) of an 
individual has also been disputed to be involved in the pathogenesis of dengue, where most of 
the postulated theories revolve around secondary infections. In our study, the main limitation 
was the small sample size, hence we could not categorize infection status by the respective 
dengue classification and hence only decipher the cytokine levels of primary and secondary 
infected dengue patients as a whole at different time point of illness. Eotaxin, IP-10 and 
ICAM-1 were significantly higher in secondary infected dengue patients during the febrile 
phase of illness. Increased levels ICAM-1 have been indicated in endothelium damage and 
activation , and 75% of the secondary cases in our cohort were of patients with warning signs 
and/or with severe dengue. Likewise, eotaxin levels which were higher in patients with 
warning signs have been demonstrated to increase permeability of human coronary artery 
endothelial cells by downregulating tight junction proteins . IP-10 levels were significantly 
higher in the overall dengue patients, indicating a more vigorous inflammatory response in 
secondary infections. Radhakrishnan et al. During the defervescence phase, 4 other cytokines 
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displayed significantly lower levels in secondary dengue cases, which were IFN-gamma, 
RANTES, PDGF and G-CSF. Interferon-gamma is a critical cytokine in the innate and 
adaptive immunity against viral infections. Lower levels of this cytokine during a secondary 
infection indicate defective ability to inhibit viral replication or to be immunomodulatory. 
RANTES recruits lymphocytes and NK cells to sites of inflammation, and in an influenza 
mice model deficient in RANTES/CCL5, delayed viral clearance and excessive inflammation 
occurred . PDGF which promotes cellular proliferation and inhibits apoptosis and is an 
integral component for maintaining the vascular networks is lower in secondary infections 
offering a possible explanation as to why secondary infected patients suffered from vascular 
leakage. GCSF, a WBC stimulating factor, is lower in secondary infections in line with the 
occurrence of leukopenia and neutropenia in such cases . In dengue patients without warning 
signs, a decrease in platelets was noted during defervescence, and this was correlated strongly 
with RANTES and VEGF.  
Gear ARL et al. Both RANTES, a chemokine stored in a-granules of platelets, 
secreted upon platelet activation , and VEGF, a growth factor released by platelets, would be 
expected to decrease upon thrombocytopenia. The defervescing DwoWS patients also had 
increased levels of liver enzymes AST, ALT and Gamma-GT. Raised AST levels during 
acute liver damage, has been associated with secreted IL-1ra which is an acute phase protein  
produced by liver cells and also with IL-10, an antiinflammatory cytokine which have 
previously correlated to necroinflammatory activity in liver damaged hepatitis C patients . 
ALT, an enzyme present in hepatocytes was linked to IP-10 which is known to be induced in 
the liver. This cytokine plays a specific role in the intralobular accumulation of mononuclear 
cells and/or the death of hepatocytes in chronic hepatitis . The gamma-GT levels, on the other 
hand were associated with IL-4, IL-12 and IL-9. Schistosomal patients with hepatic damage 
were found to have high levels of IL-4  indicating an active Th2 immune response which 
could also be the situation in dengue patients. Elevated levels of IL-12 have been shown to be 
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associated with liver damage in various studies conducted . At the convalescence phase, these 
without warning signs patients who had high levels of monocytes were associated with the 
increased levels of VEGF which possibly could be due to the involvement of VEGF in 
monocytes activation . Surprisingly though, VEGF was inversely correlated to neutrophils. 
These patients also had high AST levels which was negatively associated with the decreasing 
levels of MCP-1 which have been implicated in the liver injury process . Dengue patients 
with warning signs also exhibited thrombocytopenia, however, this clinical feature began 
earlier during the febrile phase and lasted till defervescence. A total of 6 different cytokines 
were thought to have possible association with platelet destruction, with 3 (IL-7, IL-12 and 
PDGF) occurring at both febrile and defervescence. IL-12 has been known to stimulate 
platelet-activating factor (PAF) and the decrease of the cytokine probably disallowed normal 
platelet aggregation and degranulation. The platelets are also known to release several growth 
factors, which probably explain the decreased levels of both VEGF and PDGF in the event of 
thrombocytopenia. Elevated levels of IL-7, conversely, have been previously shown to be 
involved in thrombocytosis . During defervescence, the low levels of IL-5 probably 
deregulated functional PAF on eosinophils . The presence of atypical lymphocytes in patients 
with warning signs from defervescence onwards was associated with G-CSF and IP-10. The 
AST enzyme in dengue patients with warning signs was raised throughout the illness, and 
this enzyme was associated with (i) at the febrile phase- ICAM-1, FGF-Basic, IL-13, IL-4, 
IL-12 and VEGF; (ii) defervescence: PDGF and (iii) convalescence- IFN-c and IP-10. 
ICAM-1 has been suggested to play a role in inflammatory liver diseases by recruiting 
leukocytes which can injure tissue by releasing various proteases and oxidants. The anti-
inflammatory cytokines, IL-13 and IL-4 has been known to have hepatoprotective effects . 
IL-12 overexpression, as pointed out earlier, had been involved in liver damage, and many of 
its effects has been implied to be mediated by IFN-gamma. IFN- gamma has also been 
suggested to be a negative regulator in liver cell proliferation and also to aggravate hepatitis 
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viral-induced liver damage . In an adult liver, endothelial cells provide nutritional and trophic 
support  and these cells are activated by VEGF and PDGF, whereby an association of 
decreased levels of VEGF was noticed with elevated levels of AST.  
 
Beatriz Sierra et al.Individuals exposed to a particular DENV serotype long before are 
at particular high risk to develop DHF/DSS after exposure to a heterologous but not to a 
homologous DENV serotype . Our ex vivo model of DENV-1–3 stimulation of PBMC from 
individuals exposed to DENV-1 in 1977 or DENV-2 in 1981 simulates this situation. 
Remarkably, exposure to serotype cross-reactive DENV triggered a significantly higher     
IFN-c and TNF-a gene expression than serotype-specific stimulation . At protein level,            
IFN-gamma levels in DENV-1 immune individuals were 2.2- and 4.1-fold higher following 
exposure to DENV-2 and -3, respectively, compared to homologous DENV-1 stimulation           
(p < 0.01) . Similarly, DENV-2 immune individuals secreted 3.2- and 3.1-fold more IFN 
gamma in response to heterologous DENV-1/3 re-exposure, respectively, compared with 
homologous DENV-2 stimulation (p < 0.01) . On the contrary, the analysis of the expression 
of the regulatory cytokines IL-10 and TGF-beta  in response to heterologous stimulation 
showed no significant differences compare to mock In contrast, response to homologous 
DENV re-challenge showed significantly higher expression of IFN-c and TNF-a compared to 
the mock, but also a higher up-regulation of TGF-b and IL-10 gene expression in for both 
DENV-1 and DENV-2 immune individuals. At protein level, IL-10 was about twofold higher 
expressed, following homologous vs. heterologous re-challenge, and confirming the PCR 
data. 
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Humoral immunity is commonly involved in DHF/DSS pathogenesis, particularly in 
patients with a secondary DENV infection. ADE, a phenomenon in which non-neutralizing 
antibodies cross-react with heterogeneous serotypes of DENV and facilitate their binding 
with Fcγ receptor-bearing cells, facilitates severe DHF/DSS during DENV infection halstead 
et al. . The generation of antibodies against the DENV E and prM proteins is fundamental for 
host defense; however, such immune responses may increase the risk of developing 
DHF/DSS upon re-infection, primarily due to the effects of ADE. In addition to the extrinsic 
ADE pathway, in which the Fcγ receptor directly facilitates DENV binding onto the cell 
surface for DENV infection/replication, an intrinsic ADE pathway induces IL-10-mediated 
immunosuppression Ubol et al. . For the intrinsic pathway, the ADE of DENV infection 
triggers IL-10 production through an immune complex associated with the Fcγ receptor to 
enhance the infection severity. In the presence of ADE, the Fcγ receptor can facilitate viral 
 
 
34 
 
entry and trigger intracellular signaling. Moreover, IL-10 overproduction can enhance 
downstream signaling protein suppressor of cytokine signaling (SOCS) 3 expression, 
followed by type I IFN signaling suppression in the human monocyte cell line THP-1 Couper 
KN et al.. However, the molecular mechanisms of host and viral regulation of IL-10 
expression and the pathological role of IL-10 in DENV infection are mostly unknown. 
Therefore, the generation of autoimmunity and ADE may cause concerns for vaccine 
development against DENV infection. Both viral particles acting through the extrinsic 
pathway and Fcγ receptor signaling through the intrinsic pathway are important for IL-10 
induction. To clarify the potential effects of these regulatory routes, determining the detailed 
molecular mechanisms underlying DENV-induced IL-10 production is an important target for 
research.  
IL-10 expression and activation : 
Wilson et al..The balance between inflammation and anti-inflammation is critical for 
infection control IL-10, which was originally named cytokine synthesis inhibitory factor, is a 
cytokine that is produced by type 2 T-helper cells Filbloom et al. . IL-10 exhibits anti-
inflammatory properties, including the inhibition of immune mediator secretion, antigen 
presentation, and phagocytosis . Currently, 6 IL-10-related cytokines, including IL-10, IL-19, 
IL-20, IL-22, IL-24, and IL-26, have been identified . All IL-10 family members utilize 
similar receptor complexes. Two transmembrane glycoproteins, IL-10 receptor (IL-10R) 1 
and IL10R2, form the complete IL-10R. There are 2 steps involved in the initiation of IL-10 
signaling. IL-10 first binds to IL-10R1, and the interaction between IL-10/IL-10R1 changes 
the conformation of the IL-10/IL-10R1 complex to facilitate the interaction between IL10/IL-
10R1 and IL-10R2 (Webernordt et al.). The cross-reaction of IL-10Rs induces the Janus 
kinase (Jak) 1/Tyrosine kinase (Tyk) 2-mediated phosphorylation of IL-10R1 at tyrosine 
residue 446/496. Subsequently, STAT3 binding induces auto-phosphorylation , followed by 
downstream gene transcription. 
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Felipe Campos de Melo Iani et al. Higher levels of IL-10 were found in samples 
positive for DENV-3 than for DENV-1 and DENV-2. These differences suggest that viral 
serotypes may have distinct host–pathogen interactions, which could imply changes in 
disease progression. This adds to the concept that different serotypes can induce distinct 
inflammatory responses due to their unique antigenic variation. The imbalanced and 
deregulated cell-mediated immunity is a pivotal component in DENV infection.  
Vaughn DW et al. Activation of T lymphocytes leads to the production of pro-
inflammatory cytokines (i.e., TNF-alpha, IFN- gamma) that may be pathogenic in the context 
of excessive T-cell activation, which is commonly observed in severe dengue.However, in 
our studies, we examined a window in time only 1–4 days after the onset of symptoms, when 
the innate response might play a more crucial role in generating the immune cytokine profile. 
Clyde K et al. The balance between inflammation and anti-inflammation is critical for 
infection control. It has been increasingly recognized that the inflammatory response and the 
production of regulatory cytokines play key roles in the development of severe clinical 
manifestations, for which the rapid increase in cytokine levels seems to be a predominant 
factor in disease severity. 
Inflammatory cytokines help fight the virus and anti-inflammatory cytokines such as 
IL-10 can avoid excessive inflammation (usually damaging the host organism). Increased 
levels of serum IL-10 may be a useful prognostic hallmark in DHF/DSS patients. 
Chaturvedi UC Aberrant IL-10 expression may also be involved in DENV 
pathogenesis, particularly for DENV infection/replication under antibody-dependent 
enhancement as demonstrated in vitro. Correlation analyses were performed between 
inflammatory (IL-6 and IL-8) and antiinflammatory (IL-10) cytokines in both groups (HM 
and NHM) to identify the response profile of HM and NHM groups. Interestingly, the NHM 
group demonstrated a significant correlation with the production of both inflammatory 
cytokines, and also with the production of the regulatory cytokine IL-10, which was not 
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observed with the HM group. These data suggest that the intensification of the disease (with 
the appearance of HM) may be due to the loss of the fine balance required between pro- and 
anti-inflammatory immune responses 
Tsai et al. Schematically describes the production of IL-10 during inflammatory 
response 
 
 
  
                                         
Quantative estimation of IL-10 using qPCR 
                                                              Pandey et al. 2015 
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Pandey et al. found peak levels of IL-10 on the day of defervescence and the day 
before defervescence in dengue cases. In another study, IL-10 levels appeared to peak after 
defervescence . This may reﬂect the distinct sources of IL10, including infected macrophages 
during the early phase of the disease and regulatory T cells in the later phase of the illness. A 
recent study reported a high level of IL-10 during DV infection . In the present study, levels 
of IL10 were signiﬁcantly increased in the presence of melena (a sign of gastrointestinal 
bleeding). High serum levels of anti-inﬂammatory cytokines such as IL-10 were also found in 
DHF . Elevated levels of IL-10 in DHF patients compared to DF patients, reﬂecting an 
enhanced regulatory response to the more intense immune activation in DHF, has been 
demonstrated. 
 
Radhakrishnan et al.Fifteen different inflammatory cytokines were analyzed where 
the majority of them were pro-inflammatory while only 4 were anti-inflammatory. Of these, 
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various trends were observed, notably, among the proinflammatory cytokines, with only the 
mean cytokine levels of IL18 were elevated for both groups of patients at all three phases of 
illness. The levels of pro-inflammatory cytokines, IL-5 and IL-12 as well as anti-
inflammatory cytokine IL-4 were lower throughout the illness in both groups when compared 
to the healthy controls. The IFN-gamma levels were generally lower in DwoWS patients and 
were higher in DwWS patients with decreasing trend as patients recovered. The cytokines IL-
1b and TNF-a displayed a similar trend where lower levels were detected during febrile 
phase, which then peaked during defervescence. The levels of IL-6 were generally higher in 
DwWS patients, but during defervescence, DwoWS patients had high levels similar to the 
warning signs group. Both groups displayed higher levels of IL-9 than controls, but the 
patients with warning signs had peak levels during defervescence. Anti-inflammatory 
cytokines, IL-10 and IL-13 showed mixed patterns, whereas IL-1ra in both groups displayed 
similar a trend throughout the disease, however with the warning signs group having higher 
levels than the DwoWS patients. Two cytokines (IL-2 and IL-17) had insufficient patient 
response in both groups. Despite the various trends observed, none of the inflammatory 
cytokines were significantly different between the groups studied at any time point. ii. 
Chemokines. More than half of the chemokines analysed, namely IP-10, MCP-1, MIP-1b, 
and RANTES, had elevated mean cytokine levels in both patient with and without warning 
signs across the three time points. Notably, IP-10 levels in both groups were significantly 
different from healthy donors at febrile (DwoWS: P,0.01; DwWS: P,0.001) and 
defervescence (DwoWS: P,0.001; DwWS: P,0.01) phases . In the case of MIP-1b, a 
significant difference was noted in the DwoWS during defervescence (P,0.01) and in the 
DwWS patients in the febrile phase (P,0.05) of disease compared to the controls Further, the 
MCP-1 was significantly higher (P,0.01) in the warning signs patients during the febrile stage 
when compared to the controls Eotaxin was generally lower in DwoWS patients and higher in 
DwWS patients and IL-8 was higher in patients without warning signs compared to the 
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DwWS. iii. Adhesion molecules and growth factors - The only adhesion molecule studied, 
ICAM-1, had mean levels that were slightly elevated in both groups of patients. In contrast, 
the mean levels of growth factors, FGF-Basic and G-CSF, were decreased in both groups 
relative to normal groups at all the three phases of illness, with a significant decrease for G-
CSF in the patients’ without warning signs (P,0.05)  during defervescence. Other growth 
factors, IL-7, PDGF and VEGF were generally lower in patients with warning signs, relative 
to both patients without warning signs and the normal group. Growth factor GM-CSF lacked 
data for in group without warning signs. 
Levels of Cytokines in Primary Versus Secondary Infections The differences in 
cytokines levels were also assessed between the 16 primary infected patients and the 28 
patients who were experiencing secondary infections. Of the 29 cytokines analyzed, most 
displayed relatively similar levels in both infection statuses. However, at the febrile phase, we 
found that 3 cytokines differed significantly where eotaxin, IP-10 and ICAM-1 were 
significantly higher in patient with secondary infections (Figure 3). At the defervescence 
phase, on the other hand, pro-inflammatory cytokine IFN-c, chemokine RANTES and growth 
factors, PDGF as well as G-CSF, were found to be significantly higher in primarily infected 
patients than those suffering from secondary infections . 
Generally, in patients without warning signs, we found that the decreased levels of 
platelet were associated with the decreasing levels of VEGF and RANTES during 
defervescence. At this phase, the augmented liver enzymes were associated with several 
cytokines where AST was associated with increased levels of IL1ra and IL-10; ALT with IP-
10 and Gamma-GT with IL-4, IL-12 and IL-9. In the convalescence phase, the increased 
levels of AST were conversely related to the decreasing levels of MCP-1. Whereas, the 
increased levels of VEGF at this time point, was associated with the decreased levels of 
neutrophils and higher state of lymphocytes. Significant associations between the decreased 
levels of IL-7, IL12 and PDGF with the decreased levels of platelet were observed in patients 
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with warning signs during the febrile phase, whereas in the defervescence, another 3 
cytokines (IL-5, RANTES and VEGF) were also associated with platelet levels. In 
defervescing DwWS patients, we also observed an association between the increased levels 
of atypical lymphocytes and the decreased levels of G-CSF. While during convalescence, an 
association was noted between the atypical lymphocytes and the decreasing levels of IP10 in 
these patients. The convalescing patients with warning signs also showed association between 
the increased levels of IL-7 and monocytes. At all 3 phases of illness, the increased levels of 
liver enzyme AST was associated with various cytokines where in febrile, ALT was 
correlated to increased levels of ICAM-1 and decreased levels of FGF-Basic, IL-13, IL-4, IL-
12 and VEGF. During defervescence, AST was associated with decreased levels of PDGF, 
whereas at convalescence, it was linked with the increased levels of IL-10, and IFN-gamma. 
Angiolillo AL et al.IP-10, an important mediator in inflammatory response, was 
shown to inhibit dengue infection through competitive binding of heparan sulphate on host 
cell membrane. Initially during the febrile and defervescence stage, both groups of patients 
demonstrated significant high levels of IP-10, however, the levels declined steadily for 
patients without warning signs throughout the phases. However, it remained high in patients 
with warning signs, offering a possibility that it may be affecting vascular permeability as IP-
10 is a potent inhibitor of angiogenesis in vivo. 
           
Dengue and Interferon gamma  
 
Liberty et al. The role of IFN-gamma in dengue immunity is unclear. Some studies 
indicate a negative role for IFN-gamma, reporting that IFN-gamma may augment antibody-
dependent enhancement . Others report increased serum levels of IFN-gamma in naturally 
infected patients, and show a correlation between serum IFN-gamma levels and disease 
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severity. The protective role IFN-_ may play in dengue infection is demonstrated by in vitro 
experiments with dendritic cells .  
Kurane et al.When human myeloid dendritic cells were infected with dengue in the 
presence of IFN-gamma these cells showed enhanced IL-12p70 release and an enhanced state 
of activation. In other studies the addition of IFN-gamma to a culture containing a dengue 
virus-specific CD8+ human T lymphocyte clone augmented dengue virus-specific cytotoxic 
activity, which suggests a role for this lymphokine in the growth and maintenance of dengue-
specific cytotoxic activity. Early investigation into the role that IFN-gamma may play in the 
infection of a human monocytic cell line (U937) suggested that this lymphokine may enhance 
infection of human monocytes .Other investigators showed that IFN-gamma has amore 
variable effect on dengue infection depending on the cell type and pathway of infection.   
Taken together, the above information clearly defines a need to better understand the role 
IFN-gamma plays in dengue infection. 
 
Kotney et al. Of the TH1 associated cytokines measured in this study, IFN-gamma 
secretion during the acute phase of illness provides the best evidence for a TH1 protective 
response against dengue infection.IFN-gamma is a pleiotropic lymphokine that has a very 
complex role in regulating the immune system and controlling infectious disease . Cytotoxic 
CD8+ T cells , NK cells , and CD4+ cells of the TH1 phenotype  are the main cellular 
producers of IFN-gamma The important role that IFN-gamma plays in antiviral defense has 
been demonstrated in a wide range of viral infections and data from this study suggests that 
sustained levels of IFN-gamma may correlate with protection against dengue challenge. 
Others hypothesize a negative role for IFN-gamma reporting that IFN-gamma may augment 
antibody-dependent enhancement by upregulating the expression of Fc_R on monocytic cell 
lines , and others report a correlation between serum IFN-gamma levels and disease severity . 
Monocyte function is dependent upon activation by IFN-gamma and up-regulation of the 
 
 
42 
 
high affinity receptor of IgG (Fc_RI) allows the monocyte to phagocytose foreign particles, 
bind immune-complexes, and perform antibody dependent celluar cytotoxitity; all functions 
that are necessary in the clearance of pathogens from the host. In most viral infections, the 
enhancement of monocyte function is crucial to viral clearance, however, in the case of 
dengue, some believe that Fc-mediated uptake of dengue virus can enhance disease , 
especially when  anti-dengue antibody titers are low.  
Sonnenfeld et al. The correlation reported between serum IFN-gamma levels and 
diseaseseverity lead to the inference that over stimulation of the cellular immune response 
may play amajor role in disease pathology . The evidence is highly suggestive that cellular 
immunity is somehow not properly regulated in cases of severe disease. In this study, we 
show evidence that dengue virus may somehow suppress cellular immunity during the time 
of peak viral replication by amechanism that temporarily inhibits IFN-gamma production by 
stimulated PBMC. A similar observation was made in a study that examined virus-specific T 
cell responses in Thai children; authorsunexpectedly found that IFN-gamma T cell responses 
were absent during the acute phase of illness . The possible mechanism for transient 
suppression of IFN-gamma responses is unknown. But since the suppression occurs during 
time of peak viral replication it is highly likely that one of the dengue non-structural proteins 
may interfere in IFN-gamma production, secretion or stability. Dengue non-structural 
proteins suppress immune activation by inhibitinginterferon alpha/beta signaling , and it may 
be possible that the same or other non-structural dengue proteins could interfere in the 
signaling pathway for IFN-gamma Similar suppression of IFN-gamma and IL-2 was 
observed in mice re-stimulated with hepatitis B core antigen after one or two immunizations .  
Authors showed that suppression of IFN-gamma after re-stimulation with hepatitis B 
core antigen was mediated by CD25+ T cells, since IFN-gamma responses returned to normal 
levels when cultures were depleted of CD25+ T cells prior to re-stimulation. Taken together, 
the evidence from this study and the others mentioned above supports the importance of 
 
 
43 
 
proper immune regulation in the control of disease progression. Most importantly, the human 
challenge study is the first study to provide evidence that sustained IFN-gamma production 
after infection may play a key role in protection against dengue 
T Pal et al. states that Serum IFN-gamma level in age matched control group ranged 
from 0.9 to 18.79 pg/ml with mean value of 3.24 pg/ml. IFN-gamma level of High-VL group 
ranged from 1.96 to 62.4 pg/ml with mean value of 11.38 pg/ml. Interestingly, IFN-gamma 
level of Low-VL group was higher than the other groups – ranging from 5.04 to230.44 pg/ml, 
with mean value of 67.82 pg/ml (Fig. 5). Significant negative correlation of serum IFN-
gamma level was observed with DENV load (P value: 0.0001). Nausea, leucopenia, persistent 
vomi-ting and abdominal pain were significantly negatively correlated with serum IFN-
gamma level (P value < 0.05). 
Anushya et al. IFN-gamma T-cell Response in the Dengue Population Presentation of 
antigenic peptides by the HLA molecules on APCs will activate cell-mediated immunity. 
Improper activation of these cells, mainly the cytotoxic T lymphocytes, has been suggested to 
play a role in dengue severity. Therefore, we sought to investigate the T cell activation of 
dengue infected patients via IFN-gamma ELISpot. First, the designed peptides were pooled to 
evaluate the T cell responses of 156 dengue positive patients from the study population who 
were HLA-typed. 78.2% patients were with warning signs whereas the rest were patients 
from the dengue positive ND and DwoWS groups. Patients in the ‘‘without warning signs’’ 
group did not exhibit any warning signs or severe manifestations. A positive response was 
ascertained for when the number of SFC per million PBMCs of patients were twice as much 
as that of negative control wells, and above the cutoff point generated from ELISpot data of 
the healthy donors. Twenty-five dengue patients displayed positive T cell responses to at least 
one of the peptide pools and 84% were patients with warning signs. Generally, patients had 
higher magnitude of response in peptide pools (Pool C, D, E and F) consisting of the non-
structural (NS) proteins. It was also observed that patients with warning signs had larger 
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magnitudes of responses; however no significant differences were found between patients 
with and without any signs in any of the pooled peptides. All 25 pooled peptide patients 
responded to at least one individual peptide .Generally most patients tested responded to 
peptides designed based on the non-structural proteins where peptide 15 (NS1187–195 
AVKDERAVH) and peptide 17 (NS2A179–188 PLCLSTTSQK) had the highest number of 
respondents. This was followed by peptides 16 (NS1297–306 SLRTTTVSGK), 220 
(NS2B59–13 NEGVMAVGL), 229 (NS4B159–167 VVYDAKFEK). In the non structural 
region, NS5 had the lowest T cell response among the patients tested. The response in the 
structural protein was much lower, with the capsid region peptides generating the most 
responders. 
T.Pal et al. 
         2015 
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CYTOKINE PROFILE IN DF AND DHF PATIENTS 
Natalia Houghton-Trivin ˜o 
2010 
 
It is believed that an increase in viral load is an initial event in DHF pathogenesis and 
has an indirect effect on the endothelium by immune mediators released by infected cells 
(Green & Rothman, 2006). In this study, there was no significant correlation with disease 
severity; however, DHF/DSS patients presented higher TNF-a and IL-8 pro-inflammatory 
cytokine levels. TNF-a is known to act directly on vascular endothelium and cause changes in 
vascular permeability (Chakravarti & Kumaria, 2006; Chen et al., 2007). IL-8 is known to be 
associated with changes in vascular permeability in vitro (Talavera et al., 2004), and elevated 
levels of IL-8 were found in patients with DHF/DSS (Raghupathy et al., 1998). IL-10 levels 
were higher in DHF patients than in DF patients. Earlier studies have shown significantly 
higher levels of IL10 in patients with DHF/DSS (Chen et al., 2005; Pe ´rez et al., 2004). 
Taken together, these results suggest that viral load or cytokines probably influence dengue 
severity, but this depends on other factors such as age of the host, virus serotypes, sequential 
infections of different virus serotypes and cytokine profile. Mortality was not found among 
the group of patients studied, even in patients suffering from the most severe DHF, raising 
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the question of whether host factors can control the immune response and whether sST2 
could contribute to this control. Sera from DHF patients induced marked activation in 
HUVECs, partly due to the effect of TNF-a, a proinflammatory cytokine previously reported 
to be present during DENV infection (Cardier et al., 2005; Green & Rothman, 2006). It also 
resulted in a significant increase in sST2 expression. Such data strongly indicate that TNF-
alpha is important for sST2 expression in endothelial cells, although the contribution of other 
factors in serum cannot be excluded. It is unlikely that sST2 upregulation is due to active 
virus replication in HUVECs, as in most cases no virus was detected in cells incubated with 
patient sera. qPCR analysis revealed a strong deregulation of ST2L expression in HUVECs 
treated with sera from volunteers and patients; however, ST2L was upregulated at 24 h in 
response to inflammatory (hrTNF-a) and proliferative (DMEM with 20% FCS) stimuli, as 
reported previously (Kumar et al., 1997). These results indicate that different mechanisms 
regulate sST2 and ST2L isoform expression. Transcription factors activated by sera from 
dengue patients could preferentially bind to a promoter that stimulates sST2 expression and 
consequently become favoured. 
sST2 function during DENV infection remains unknown. High sST2 serum levels 
have been found in patients with severe asthma (Oshikawa et al., 2001). Nevertheless, it is 
thought that sST2 binds to IL-33 and inhibits its binding to ST2L to block NF-kB activation 
and Th2 cytokine expression, which suggest that sST2 modulates IL-33 biological activity 
during allergic inflammation (Hayakawa et al., 2007). Recombinant sST2 also suppresses 
proinflammatory cytokine production following stimulation with LPS in macrophages and 
monocytes. It also promotes reduced TLR-4 expression and IkB degradation (Sweet et al., 
2001; Takezako et al., 2006). Administering sST2 to mice after intestinal ischaemia results in 
reduced TNF-a production and inhibition of vascular permeability, neutrophilia and 
haemorrhagia in the intestine and lungs (Fagundes et al., 2007). However, plasmid sST2 
expression in vivo markedly inhibits hepatic damage and TNF-a and IL-6 inflammatory 
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cytokine production in a mouse model of ischaemia of the liver (Yin et al., 2006). These 
examples show that the association between ST2 and different inflammatory diseases is not 
always causal, and that the functions could be pathogenic or protective. ST2 could be 
involved as a negative regulatory mechanism in response to TNF-a and/or other pro-
inflammatory cytokines to prevent an uncontrolled immune reaction. Nevertheless, such an 
immunosuppressive effect could be an immune evasion strategy implemented by DENV. 
Blocking IL-33– ST2L binding could inhibit polarization towards a Th2 response and 
prolong the Th1 inflammatory response. Preliminary results using qPCR and ELISA did not 
show increased expression of IL-33 mRNA in PBMCs from dengue patients nor differences 
in the levels of soluble IL33 in DHF and DF patient sera (data not shown). 
Natalia et al. found that patients with acute-phase DHF/DSS had greater sST2 levels 
than DF patients or controls, and that sST2 could be a marker of disease severity. For this 
study group, circulating sST2 may have originated from PBMCs, or may have originated 
from endothelial cells during the acute phase. This may be a response to immune activation 
by vasoactive and proinflammatory mediators, because HUVECs expressed ICAM-1 and 
sST2 in response to dengue patient sera, even though ST2L was not expressed and DHF 
patients had higher TNF-a levels, and experimental blocking reduced sST2 expression in 
HUVECs, indicating that TNF-a is important for sST2 expression in these cells. Further 
studies will be directed towards defining the role of sST2 in DENV infection and could 
provide new insights in interpreting the disease immune pathology. 
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INTERFERON GAMMA , TNF ALPHA , INTERLEUKIN -6 AND 8 LEVELS IN DF                  
AND DHF PATIENTS 
Priyadarshini et al. ,2015 
 
 
Priyadarshini et al. found that IFN-gamma levels A mean level of 1.3 pg/ml of IFN-
gamma was detected in healthy controls. Using 3.8 pg/ml as cut off, IFN-gamma was found 
to be significantly higher (p,0.001) in dengue patients (both DF and DHF), with a range of 
0.9 to 859.7 pg/ml. The mean level of IFN gamma in DF cases was higher compared to the 
mean level in DHF patients . The number of cases showing increased IFN-gamma levels was 
larger in the DHF category (66.1%, n=41) as compared to DF cases (58.4%, n=93) . 
TNF-alpha levels The mean level of TNF-alpha in healthy controls was 3 pg/ml and 
the cut off was 5.5 pg/ml. The concentration of TNF-alpha ranged from 0 to 184 pg/ml in 
dengue patients . The mean values of DF and DHF were lower than that of healthy controls 
(p.0.05). 
A.L. Rothman et al.IFN-gamma/TNF-alpha  are key players in cell-mediated 
inflammation, both in infectious and non-infectious diseases, being controlled by anti-
inflammatory cytokines, like TGF-b and IL-10 . The equilibrium between these two branches 
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of the immune response is important for a balanced and effective control of the dengue 
infection.  
U.C. Chaturvedi  et al.The incontrollable inflammatory response (IFN-c/ TNF-alpha ) 
in the absence of an adequate regulatory control (TGF-beta/ IL-10) could explain the 
enhanced risk of DHF/DSS after a heterologous re-infection in individuals exposed to DENV 
long before. It have been reported that CD4+ T cells produce TNF-alpha, IFN-gamma and 
TNF-beta after DENV stimulation, which could contribute to the pathogenesis of the 
secondary DENV infection. An increase in IFN-gamma levels results in an increase in the 
expression of Fc receptor, leading to a higher number of DENV-infected monocytes through 
the ADE mechanism and consequently to a higher T cell activation, and, in turn, to the 
release of TNF-alpha , 
J.E. Cardier et al.IFN-gamma and interleukin-2 (IL-2) . Besides lymphocytes, 
monocytes/macrophages, mast cells, endothelial cells, liver and dendritic cells are targets of 
DENV and could produce cytokines and chemokines after the infection as it has been 
reported in dengue patients . This tsunami of cytokines over a short period induces the 
disruption of vascular endothelial cells and deregulation of the haemocoagulation system, 
conducting to plasma leakage, shock, and hemorrhagic manifestations .  
Since DHF has been associated with a heterotypic secondary infection , the 
significantly higher pro-inflammatory DENV cellular immune response found in our study, in 
the serotype cross-reactive re-challenge, can be relate to the cascade of events generated 
during a heterologous infection ‘‘in vivo” contributing to the pathogenesis of DHF/DSS. The 
higher levels of TGF-b1 and IL-10 found in the homologous DENV re-challenge constitute 
an interesting finding, taking into account that the role of both mediators as regulatory and 
anti-inflammatory cytokines, has not been clearly associated to the serotype-specific 
response. It is accepted that a primary infection induces a long lasting protective homologous 
immunity .  
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Several studies correlate the over expression of pro-inflammatory cytokines and over-
activation of the immune system with dengue severity , thus expecting that a ‘‘protective 
immune status be associated to an anti-inflammatory environment. 
M.G. Guzman et al.The higher levels of IL-10 found after the homologous re-
challenge could be in apparent contradiction with the pathogenic role attributed to this 
cytokine, taking into consideration that high IL- 10 levels have been reported in DHF patients 
. However, this apparent contradiction is explainable as the high concentrations of 
inflammatory mediators like TNF-a and IFN-c, released during the clinical course of the 
severe disease, could induce the regulatory induction of high levels of IL-10 and TGF-b1. 
The regulatory activities of both cytokines are probably crucial in controlling the 
inflammatory response during dengue disease, preventing its associated immunopathogenesis 
and their actions could be related to the recovery of most patients with a secondary infection . 
Interestingly, Lühn et al. explored the role of regulatory T cells in acute dengue infection 
showed that T reg cells suppressed the production of vasoactive cytokines after 
denguespecific stimulation. Furthermore, T reg cell frequencies and also T reg cell/effector T 
cell ratios were increased in patients with acute infection, being significantly increased in 
patients with mild disease in contrast to severe cases. It is a strong indication that a relative 
rise of T reg cell/effector T cell ratios is beneficial for dengue disease outcomes. 
Cytokine proﬁle in paediatric population with DHF/DSS 
Nguyen Thanh Hung et al. The levels of IFN-gamma in the acute-phase samples from 
infants with DHF/DSS were signiﬁcantly higher than those in samples from healthy control 
infants (mean, 56.2 vs. 4.1 pg/mL; ; ). When the data are pooled and the kinetic changes in 
cytokine blood levels are plotted by day after fever onset, levels of IFNgamma in infants with 
DHF/DSS are found to have increased on day 4 to day 6 after the onset of fever and to have 
rapidly decreased on day 7 and during the convalescent phase. The concentration of IFN-
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gamma in convalescent-phase samples from the patients was somewhat higher than that for 
control subjects, but was not signiﬁcantly different (mean, 18.5 vs. 4.1 pg/mL; ; Similar 
results were observed when the TNF-a levels in the acute- and convalescent-phase samples 
were compared with those in samples from control subjects. Infants with DHF/DSS had 
signiﬁcantly higher TNF-a levels in acute-phase samples than did control subjects (mean, 9 
vs. 0.8 pg/mL; ;table P p .01 5). TNF-alpha levels were elevated on day 4 to day 7 after the 
onset of fever and decreased on day 8 to day 19; thus, the concentration of TNF-a in 
convalescent-phase samples from infants with DHF/DSS was not signiﬁcantly higher than 
that in samples from control subjects (mean, 4.4 vs. 0.8 pg/mL; ). Signiﬁcantly elevated IL-
10 and IL-6 levels were detected in the acute-phase samples from infants with DHF/DSS, 
compared with samples from control subjects (mean, 73.8 vs. 0.3 pg/mL and 28.2 vs. 1.4 
pg/mL , respectively). In contrast, IL-10 andIL-6 levels in convalescent-phase samples from 
infants with DHF/DSS decreased, compared with levels in acute-phase samples, but were still 
signiﬁcantly higher than in samples from control subjects (mean, 8.3 vs. 0.3 pg/mL  and 22.7 
vs. 1.4 pg/mL , respectively). However, further analysis showed that the mean serum levels 
of IFN-gamma, TNF-alpha, IL-10, and IL-6 did not differ signiﬁcantly between patients with 
no shock DHF and those with DSS. 
Yadav M et al. has stated that Early diagnosis, proper treatment, and good nursing 
care are the principles of management of DHF/DSS in infants, as well as in children. 
Although the incidence of DHF/DSS in infants was low (∼5%), the number of severe cases 
and the mortality rate were high among infants, compared with among older children. In the 
present study, almost all patients completely recovered, but 4 patients died, resulting in a 
rather high case-fatality rate of 3.7%. In comparison, the case-fatality rate was !1% among all 
patients with DHF/DSS in the same time period . There are many reports that cytokine blood 
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levels in patients with DF differ from those in patients with DHF/DSS. All such data are from 
studies of secondary dengue virus infections in older children and adults . 
Nguyen Thanh Hung et al Unusually high levels of cytokines may play a role in the 
pathogenesis of DHF in infants. To investigate whether there is any difference in the cytokine 
proﬁles of paediatric patients with primary dengue virus infections and older children with 
secondary infections, we measured the concentrations of cytokines in 39 children with 
DHF/DSS aged 4–15 years who had secondary dengue virus infections, using the same 
techniques described in the present study. We found signiﬁcant elevations of serum IFN-
gamma and IL-10 levels in children with DHF/DSS (  mean and SD 109.5, 225.7 pg/mL, 
respectively), compared with levels in control and subjects were 78.9  ,57.6  pg/mL, 
respectively. Serum levels of TNF-alpha, IL-6, IL-4, and IL-2 were not elevated in children 
with DHF/DSS who had secondary dengue virus infections . 
Rothman AL et al. The levels of IFN gamma and IL-10 in children with secondary 
dengue virus infections did not differ from those in infants with primary dengue virus 
infections. Instead, the cytokine proﬁle differed. In contrast to children with DHF/DSS, who 
produce elevated levels of IFN gamma and IL-10, infants produced elevated levels of TNF-a 
and IL-6, in addition to IFN-gammaand IL-10.  
Nguyen Thanh Hung et al. It is evident that, in opposition to the view of Rothman and 
Ennis , cross reactive T cells that are activated in response to secondary infection with a 
different serotype are not required to produce the high levels of cytokines that accompany 
severe DHF. A unifying hypothesis is that enhancing antibodies acquired passively from 
mothers (primary infection in infants) or actively from previous infection (secondary 
infection in children) promotes dengue virus infection of Fc-bearing cells, resulting in a large, 
infected cell mass. T cell and cytokine responses are simply proportional to the infected cell 
mass. Levels of the inﬂammatory cytokine IFN-g and the anti-inﬂammatorycytokineIL10 are 
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elevated simultaneously in patients with DHF/DSS. Infants experiencing DHF during 
primary dengue virus infection also have elevated blood levels of TNF-alpha  and IL-6. 
Linear regression analysis revealed that levels of cytokines such as TNF-a, IL-6, and IL-10 
are correlated with some biological responses. An elevated serum level of TNF-alpha has a 
signiﬁcant correlation with the increase in Hct that is a sign of capillary leakage in infants 
with DHF/DSS. This may be the result of TNF-alpha toxicity to vascular endothelial cells 
and may increase vascular permeability. There were signiﬁcantly higher levels of IL-6 in 
infants with fatal outcome, compared with levels in those who survived the infection . But no 
p .007 signiﬁcant difference exists between patients with and patients without shock. The 
serum level of IL-6 in infants with DHF/ DSS was also strongly correlated with activation of 
the extrinsic pathway of coagulation (PT; ) but not with the intrinsic pathway (APTT) or with 
ﬁbrinogen levels. Furthermore, a signiﬁcant and strong correlation between IL-10 and serum 
levels of AST and ALT was found in infants with DHF/DSS.  
Green et al.  reported that elevated levels of IL-10 in children with dengue virus 
infection were associated with disease severity (DF vs. DHF) and the degree of capillary 
leakage, quantiﬁed by the size of pleural effusions. The elevation of IL-6 and IL-10 levels in 
infants with DHF/DSS suggests that, when an infantresponds to dengue virus infection via 
generation of inﬂammatory cytokines (IFN-gamma and TNF-alpha), there is simultaneous 
generation of inhibitory cytokines (IL-6 and IL-10) to counteract the inﬂammation. The more 
stimulation of the pathogen, the higher the levels of stress mediators, such as IL-6 or IL-10, 
induced in the host to counteract the response.  
Lei HY et al.Cytokines can cause cell activation synergistically or antagonistically; 
the net outcome will depend on the balance between various cytokine actions . The present 
study emphasizes that DHF/DSS in infants is not uncommon and that clinical characteristics 
and laboratory ﬁndings for infants with DHF/DSS are compatible with the WHO case 
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deﬁnition for DHF/DSS in children. This study is the ﬁrst to describe cytokine blood levels 
during the acute stage of DHF/DSS in infants. The cytokine proﬁle in infants with primary 
dengue virus infections and children with secondary infections were studied in the same 
laboratory, using the same assay methods. Overproduction of both pro inﬂammatory 
cytokines (IFN-g and TNF-a) and anti-inﬂammatory cytokines (IL-10 and IL-6) may play a 
role in the pathogenesis of DHF/ DSS in children. 
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AIMS AND OBEJECTIVES 
 
 
55 
 
 
 To assess patients based on clinical signs and hematological profile of patients admitted 
with fever in a tertiary care centre in Tirunelveli district Tamil Nadu. 
 
 To confirm the case as one of dengue fever by regular dengue serology including Dengue 
IgM ELISA( Enzyme Linked Immuno Sorbent Assay) and NS1 protein ELISA. 
 
 To assess the levels proinflammatory cytokines- INFγ, TNFα and regulatory cytokine - 
IL-10 in these patients using ELISA. 
 
 To correlate cytokine levels with disease severity and clinical outcomes with a special 
reference to the development of Dengue Haemorrhagic Fever or Dengue Shock 
Syndrome and their utility in treatment strategies for dengue patients in the future. 
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MATERIALS AND METHODS 
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The present study was conducted at Tirunelveli Medical College, Palayamkottai  
Tirunelveli District , Tamilnadu from March to June 2017 to assess the pathophysiologic and 
prognostic role of proinflammatory and regulatory cytokines in the inpatient population 
tested positive for  dengue fever by using commercially prepared ELISA kits for IL-10, TNF- 
alpha and Interferon gamma. The levels of various cytokines were obtained using ELISA and 
statistically analysed and results were interpreted. 
STUDY DESIGN: Prospective  
STUDY AREA: Department of Microbiology -Tirunelveli Medical College 
                            Department of Medicine- Tirunelveli Medical College 
                            Department of Paediatrics- Tirunelveli Medical College 
                            
STUDY PERIOD: 1 year 
SPECIMEN: Blood samples obtained at the central laboratory for dengue serology. 
SAMPLE SIZE: 100 samples 
STUDY POPULATION:  
Inclusion criteria- children aged 4-12 years and adults 18-60 years with clinical signs 
suggestive of dengue admitted in Paediatric and Medicine wards of Tirunelveli Medical 
College. 
Exclusion criteria- Patients with fever not admitted in the hospital or those with other known 
infectious illnesses (TB/ HIV/ HCV/ malaria/ Japanese encephalitis / typhoid / chikungunya ) 
will be excluded from the study. 
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Study place and test material 
A total of 80 blood samples were collected for this study from patients who tested 
positive for Dengue IgM antibodies and NS1 protein; and with a platelet count of less than or 
equal to one lakh admitted in the Departments of Medicine and Pediatrics, Tirunelveli 
Medical College Hospital Tirunelveli. 
Test Kits  
The IgM  and NS1 ELISA kits were the ones supplied by National Insitute of Virology Pune. 
The ELISA kits for IL-10 , TNF –alpha and IFN gamma were bought from Diaclone SAS 
Pvt. Ltd. , France. Chemicals and Reagents used were those provided in the kit. 
Equipments  
The following equipments were used : 
Table top centrifuge (Remi , R8C), Incubator ( Tempo) , ELISA reader and washer (BioRad, 
France) 
Reference sera 
The controls used were those provided in the respective kits. 
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                                                                  METHODS 
General safety precautions and ethical clearance 
The blood samples were collected, transported, stored and processed using all safety 
precautions throughout the course of this study. Gloves and masks were worn during 
processing of the samples. Storage of samples were done according to the manufacturer’s 
instructions. During withdrawal of samples due care was given to follow aseptic precautions 
by using sterile disposable needles and discarded according to Biomedical Waste 
Management Rules-2016 to ensure patient safety. 
The institutional ethical clearance was obtained for this study. No charges were paid 
by patients as the study was financially assisted by Indian Council Of Medical Research, 
New Delhi. 
Collection of blood samples: 
The following steps were followed during collection of specimes 
1. Patient name, age, gender, address and platelet count (based on Complete Blood 
Count done  at Department of Pathology, Tirunelveli Medical College Hospital 
Tirunelveli) were duly written on the request form and the blood collection tube                  
( Red tube with EDTA). 
2. The patient was positioned in a chair, or sitting or lying on a bed. 
3. Blood handlers were instructed to wash hands following standard techniques before 
withdrawing blood. 
4. A suitable site for venipuncture was selected, by placing the tourniquet 3 to 4 inches 
above the selected puncture site on the patient. 
5. Non-latex gloves were worn , and the vein was palpated.  
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6. When a vein was selected, the area was cleansed in a circular motion, beginning at the 
site, working outward and  allowed to air dry.  
7. The patient was asked to make a fist; avoiding “pumping the fist.”The patient’s arm 
was grasped firmly using thumb to draw the skin taut and anchor the vein                  
(Medial cubital vein being the vein of choice). The needle was inserted through the 
skin into the lumen of the vein. The needle formed a 15-30 degree angle with the arm 
surface. 
8. The samples were collected in red vacutainers (5 ml for pediatric and 10 ml for adult 
patients)with clot activators and the needle was removed from the patient's arm using 
a swift backward motion.with the requisition forms duly signed by respective head of 
Departments. 
9. The contaminated materials/supplies were discarded in designated containers.  
10. The samples received at the laboratories were then processed. 
Blood Sample Centrifugation – It is recommended that serum be physically separated from 
contact with cells as soon as possible, with a maximum time limit of 2 hours from the time of 
collection. 
 Blood samples were centrifuged at 1800 rpm for 1 minute. 
 Tubes were kept closed at all times during the centrifugation process. 
 Place the closed tubes in the centrifuge as a “balanced load”. 
 Centrifugation safety precautions were taken care of during the process. 
 Serum separated and stored at -4degrees and vortexed before use. 
NS1 ELISA 
In accordance to the standard operating procedures of the laboratory: 
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Wash buffer preparation: 
 Diluted two parts of wash buffer in 58 parts of distilled water for 1 strip.  
Step 1. The desired number of strips were removed and secured in the microwell frame.  
Step 2 Added 50µl sample diluent into each control and test well, respectively, according to 
the designation on the ELISA worksheet. 
Step 3. Added specimens to the plate according to the designation on the ELISA working 
sheet. 
Step 3.1 . Blank wells as directed were kept empty 
Step 3.2 Control wells- Added 50µl Dengue NS1 Positive control and 50 µl NS1 Negative 
control into the designated control wells 
Step 3.3 Test wells- Added 50µl test specimens to each well. 
Step 3.4 Gently rocked the wells for 20 seconds and then covered the plate with a sealer. 
Step 4 Incubated the wells at 37º C for 60 minutes. 
Step 5 Washed with 200 microlitre wash buffer 5 times 
Step 6. Pipetted 100 µl HRP- anti dengue NS1 conjugate int each well , except the blank well 
and gently rocked the microwells to ensure thorough mixing. 
Step 7. Incubated the wells at 37º C for 60 minutes. 
Step 8  Washed with wash buffer 5 times 
Step 9 Added 50µl of TMB Substrate A and 50 µl TMB substrate B into each well. Gently 
mix for 20 seconds  
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Step 10 Incubated at room temperature in dark for 20-25 minutes. 
Step 11. Pipetted 100µl of Stop Solution to all wells and mixed well. The blue colour then 
changed to yellow. 
Step 12. Within 30 minutes read the absorbance of each well at a wavelength of 450 nm with 
a reference filter of 600-650 nano metre. 
Interpretation of Results 
The cut off value = 0.20 + N 
N: Mean OD value of the negative control.  
1. Calculation of specimen OD ratio  
Calculated the OD ratio for each specimen by dividing its OD value by the cut-off value 
as follows- 
Specimen OD ratio- Specimen OD 
                                 Cut –off value 
 
2. Assay validation  
The mean OD value of the positive controls was ≥ 0.8 
The mean OD value of the negative controls was ≤0.2 
3. Interpretation of results 
Negative – Specimen OD ratio <1.0 
Positive – Specimen OD ratio ≥ 1.0 
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IgM ELISA 
Step1 Diluted serum 1:100 with sample dilution buffer 
Step2Washed the wells thrice with buffer 
Step3 50microlitre of diluted samples were transferred to the appropriate wells 
Step4 Incubation in humidified box at 37 ºC for one hour 
Step5 The plate was then washed with200 microlitre of  wash buffer for five times 
Step6 50 microlitre of Dengue antigen was then added to each well and Incubated in 
humidified box at 37 ºC for one hour. 
Step 7 Washed five times and 50 microlitre of anti DEN monoclonal antibody conjugated 
with Horse Raddish Peroxidase was then added to each well and incubated in humidified box 
at 37 ºC for one hour 
Step8Washed five times and 100 microlitre of substrate was added to each well and 
incubated in the dark for 10minutes  
Step9 Once colour developed stop solution 100 microlitre H2SO4 was added and the 
absorbance at 450nm was measured within 10minutes. 
Quality control for NIV dengue IgM ELISA- each kit consists of Positive and Negative 
controls 
Validity –Negative control <0.18 ; Positive control > 6 times OD of Negative Control  
The sera which tested positive for NS1 and IgM was then subsequently tested for levels of 
IL-10, TNFalpha and IFN gamma using the following protocol 
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IL-10 ELISA 
Assay design – The number of microwell strips required to test the desired number of 
samples plus appropriate number of wells needed for running zeroes and standards. Standards 
were run in duplicate. 
 Preparation of wash buffer- the wash buffer was diluted 200 fold with distilled water 
to give a 1X working solution. Mixed gently and was transferred to a clean wash 
bottle and stored at 2-25 degrees. 
 Preparation of Standard diluents buffer- contents of the vial provided in the kit were 
added to 225 ml of distilled water. 
 Preparation of Standard- as serum was the sample processed , the “Standard diluents- 
serum”  was used. The vials were reconstituted with the volume of standard diluents 
immediately prior to the use. The reconstitution gave a stock solution of volume 
400pg/ml of IL-10. The reconstituted standard were mixed gently and serial dilutions 
of the standard were directly made on the assay plate to provide the concentration 
range from 400-12.5 pg/ml. 
 Preparation of controls- freeze dried control vials were reconstituted with the most 
appropriate Standard diluents for the samples provided in the kit. 
 Preparation of biotinylated IL-10 – the biotinylated IL-10 was diluted with the 
biotinylated antibody diluent in an appropriate clean glass vial using volumes 
appropriate to the number of required wells. In this case as all the 96 wells were used 
240 microlitre of biotinylated antibody was mixed with 6360 microlitre of 
biotinylated antibody diluents. 
 Preparation of Streptavidin HRP- the vial was centrifuged for a few seconds in a 
microcentrifuge to collect the volume at the bottom . The 5 microlitre vial was diluted 
immediately before use. For 96 samples we diluted 150 microlitre in 10ml diluents 
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 Assay procedure- after mixing every vial thoroughly  
Step1 100micro litre of each sample, control and zero (appropriate standard diluents 
was added to each well.(Duplicates for standards to ensure quality of assay was put) 
Step2 The plates were covered and incubated at room temperature for one hour 
Step3 Each well was then washed with 1x washing solution thrice 
Step4 50 microlitre of diluted biotinylated anti-IL10 was then added to all wells 
Step5 incubation and washing were done  
Step 6 100 microlitre of Streptavidin HRP was added to all the wells  
Step7 The plate was covered and incubated at room temperature for 30 minutes 
Step8 The wells were washed thoroughly thrice 
Step9 100 microlitre ready to use TMB substrate was then added into all wells and 
incubated in dark for 10-15 minutes at room temperature. 
Step10 The reaction was stopped by adding 100 microlitre of stop solution i.e.H2SO4 
The absorbance was then read on a spectophotometer using 450nm as the primary 
wavelength and optimally 620 nm as the reference wave length. 
INF GAMMA ELISA 
Assay design – The number of microwell strips required to test the desired number of 
samples plus appropriate number of wells needed for running zeroes and standards. Standards 
were run in duplicate. 
 Preparation of wash buffer- the wash buffer was diluted 200 fold with distilled water 
to give a 1X working solution. Mixed gently and was transferred to a clean wash 
bottle and stored at 2-25 degrees. 
 Preparation of Standard diluents buffer- contents of the vial provided in the kit were 
added to 225 ml of distilled water. 
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 Preparation of Standard- as serum was the sample processed, the “Standard diluents- 
serum” was used. The vials were reconstituted with the volume of standard diluents 
immediately prior to the use. The reconstitution gave a stock solution of volume 
400pg/ml of IFN-GAMMA. The reconstituted standard were mixed gently and serial 
dilutions of the standard were directly made on the assay plate to provide the 
concentration range from 400-12.5 pg/ml. 
 Preparation of controls- freeze dried control vials were reconstituted with the most 
appropriate Standard diluents for the samples provided in the kit was used. 
 Preparation of biotinylated IFN GAMMA – the biotinylated IFN GAMMA was 
diluted with the biotinylated antibody diluent in an appropriate clean glass vial using 
volumes appropriate to the number of required wells. In this case as all the 96 wells 
were used 240 microlitre of biotinylated antibody was mixed with 6360 microlitre of 
biotinylated antibody diluents. 
 Preparation of Streptavidin HRP- the vial was centrifuged for a few seconds in a 
microcentrifuge to collect the volume at the bottom . the 5 microlitre vial was diluted 
immediately before use. For 96 samples we diluted 150 microlitre in 10ml diluents 
 Assay procedure- after mixing every vial thoroughly  
Step1 100micro litre of each sample, control and zero (appropriate standard diluents 
was added to each well.(duplicates for standards to ensure quality of assay was put) 
Step2 50 microlitre of diluted biotinylated anti-IFN GAMMA was then added to all 
wells 
Step3 The plate was then incubated at room temperature for two hours and washing 
were done  
Step 4 100 microlitre of Streptavidin HRP was added to all the wells  
Step5 The plate was covered and incubated at room temperature for 30 minutes 
Step6 The wells were washed thoroughly thrice 
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Step7 100 microlitre ready to use TMB substrate was then added into all wells and 
incubated in dark for 10-15 minutes at room temperature. 
Step8 The reaction was stopped by adding 100 microlitre of stop solution i.e.H2SO4 
The absorbance was then read on a spectophotometer using 450nm as the primary 
wavelength and optimally 620 nm as the reference wave length. 
TNF-ALPHA 
Assay design – The number of microwell strips required to test the desired number of 
samples plus appropriate number of wells needed for running zeroes and standards. Standards 
were run in duplicate. 
 Preparation of wash buffer- the wash buffer was diluted 200 fold with distilled water 
to give a 1X working solution. Mixed gently and was transferred to a clean wash 
bottle and stored at 2-25 degrees. 
 Preparation of Standard diluents buffer- contents of the vial provided in the kit were 
added to 225 ml of distilled water. 
 Preparation of Standard- as serum was the sample processed the Standard diluents- 
serum was used. The vials were reconstituted with the volume of standard diluents 
immediately prior to the use. The reconstitution gave a stock solution of volume 
400pg/ml of TNF-ALPHA. The reconstituted standard were mixed gently and serial 
dilutions of the standard were directly made on the assay plate to provide the 
concentration range from 800-25 pg/ml. 
 Preparation of controls- freeze dried control vials were reconstituted with the most 
appropriate Standard diluents to the samples. 
 Preparation of biotinylated TNF-ALPHA – the biotinylated TNF-ALPHA was diluted 
with the biotinylated antibody diluent in an appropriate clean glass vial using volumes 
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appropriate to the number of required wells. In this case as all the 96 wells were used 
240 microlitre of biotinylated antibody was mixed with 6360 microlitre of 
biotinylated antibody diluents. 
 Preparation of Streptavidin HRP- the vial was centrifuged for a few seconds in a 
microcentrifuge to collect the volume at the bottom . The 5 microlitre vial was diluted 
immediately before use. For 96 samples we diluted 150 microlitre in 10ml diluents 
 Assay procedure- after mixing every vial thoroughly  
Step 1 100micro litre of each sample, control and zero (appropriate standard diluents 
was added to each well.(Duplicates for standards to ensure quality of assay was put) 
Step 2 50 microlitre of diluted biotinylated anti-TNF ALPHA was then added to all 
wells 
Step 3 The plate was then incubated at room temperature for three  hours and washing 
were done  
Step 4 100 microlitre of Streptavidin HRP was added to all the wells  
Step 5 The plate was covered and incubated at room temperature for 30 minutes 
Step 6 The wells were washed thoroughly thrice 
Step 7 100 microlitre ready to use TMB substrate was then added into all wells and 
incubated in dark for 10-15 minutes at room temperature. 
Step 8 The reaction was stopped by adding 100 microlitre of stop solution i.e.H2SO4 
The absorbance was then read on a spectophotometer using 450nm as the primary 
wavelength and optimally 620 nm as the reference wave length. 
The average absorbance was calculated for each set of duplicate standards and 
controls . the duplicated lied between 20% of the mean. 
The amount of cytokines was then calculated in each sample by extrapolating OD 
values against standard concentrations using the standard curve. 
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Statistical analysis 
The demographic parameters , clinical features and platelet counts were correlated 
using Chi- Square test. 
Subsequently the cytokines and their correlation with the clinical features was 
estimated individually and then a cumulative correlation of all factors, i.e. clinical features, 
platelet counts and the cytokines was estimated. 
All data were analyzed using the statistical package for social science (SPSS) 10.0 for 
Windows program on the computer. 
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RESULTS 
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5.1 COLLECTION OF TEST MATERIAL FROM PATIENTS 
The study was conducted at Tirunelveli Medical College Hospital, Palayamkottai, 
Tirunelveli district Tamilnadu  from April2017-January 2018. A total of 100 blood samples 
for this study were collected from 34 pediatric patients and 46 adult patients. Out of these 50 
were male and 50 females admitted at Tirunelveli Medical College. (table 1 and 2) .  
All these patients had tested positive for NS1 antigen and Dengue IgM ELISA 
Table 1- Distribution of Age among study population 
 Percent 
Paediatric 42.5 
Adult 57.5 
Total 100.0 
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Table 2-Distribution of Gender among study population  
 
 Percent 
1 50.0 
2 50.0 
Total 100.0 
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5.2 CLINICAL PARAMETERS 
The patients were tested for NS1 antigen of DENV and IgM antibodies against 
DENV. Positive cases were then selected for the study as per their platelet count. 
All the patients included in the study had a  platelet count of less than                        
1,00,000 / cu.mm. minimum count being 16000 and a maximum of 1,00,000 with a mean 
value  of 63,000.  
The study population was then graded based on the presenting symptoms and signs 
elicited during the hospital stay. 
Clinical features of the study population were scored (based on the WHO 
classification of dengue with and without warning signs an arbitrary scoring was done) as 
depicted in Table 3: 
     Table 3 
S.NO SIGNS AND SYMPTOMS SCORE 
1 CLINICAL FEATURES- NO BLEEDING , VAGUE SYMPTOMS   1 
2 ABDOMINAL PAIN, OEDEMA, SIGNS OF DEHYDRATION 2 
3 BLEEDING MANIFESTATIOS WITH DANGER SIGNS 3 
4 COMPENSATED SHOCK 4 
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The frequency of the clinical feature score has been shown in Table 4 
CLINICAL FEATURE SCORE  Percent 
 
1 37.5 
2 22.5 
3 28.8 
4 11.3 
 
5.2.1 CORRELATION OF AGE WITH CLINICAL FEATURES 
The comparison of age with clinical features is presented in table 5. It was found that 
the maximum number of pediatric patients did not present with significant clinical 
complications where as the adult population showed bleeding manifestations in about one 
third of cases. 
Table 5 
Count 
 CLINICALFEATURES Total 
1 2 3 4 
Age 
Paediatric N 15 9 5 5 34 
Adult N 15 9 18 4 46 
 
The correlation between clinical features and age was calculated using Pearsons Chi 
Square test. The p value and Association is depicted in table 6  
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Table 6 
 
 Value Degree of 
freedom 
Asymp. Sig. (2-
sided) 
Pearson Chi-Square 5.789 3 .122 
Likelihood Ratio 6.104 3 .107 
    
 
With the likelihood ratio of 6.104 , the p value computed was 0.025. As the Asym. 
Sig. (2 sided) is more than 0.025. Hence there was no significant correlation between age and 
clinical features . 
5.2.2 CORRELATION OF GENDER WITH CLINICAL FEATURES 
Table 7 predict the frequency of males and females with various clinical features and the 
correlation between gender and clinical features 
     Table 7 
GENDER CLINICALFEATURES Chisquare p-
value 1 2 3 4 
 
1 N 15 9 11 5  
 
0.155 
0.985 
2 N 
15 9 12 4 
 
The p value in this case was 0.025 denoting that there was no significant association 
between gender and clinical features. 
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5.2.3 CORREALATION BETWEEN PLATELET COUNT AND CLINICAL 
FEATURES 
The platelet counts of patients were compared to their clinical features by ANOVA 
test. There was a significant correlation found between the values and the clinical feature 
scores presented in table  8. 
Table 8 
 Sum of Squares Degree 
of 
freedom 
Mean Square F value Significance 
Between 
Groups 
5701866183.575 3 1900622061.192 2.909 .040 
Within Groups 49656333816.425 76 653372813.374   
Total 55358200000.000 79    
 
The F value computed was 2.909 with a significance of .040 (<0.05) and thus there was a 
positive correlation between the platelet counts and the clinical features. 
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5.3 EVALUATION OF IL-10 ELISA FOR PROGNOSIS IN DENGUE 
PATIENTS 
The IL-10 values were graded ( Based on the study of Gathsaurie Neelika Malavige1 
et al.an arbitory grading was done) as given in Table 9 
S.NO VALUES INTERPRETATION 
1 0 Negative 
2 0-10 Borderline positive 
3 11-50 Moderately High  
4 51-100 High 
5 >100 Very high  
 
The frequency of IL-10 values in patient population is depicted in Table 10 
S.No. Values Cumulative 
percent 
1 0 1.3 
2 0-10 16.3 
3 11-50 51.3 
4 51-100 70.0 
5 >100 100.0 
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One third of the dengue positive patients had very high levels of IL-10 level 
5.3.1 CORRELATION BETWEEN INTERLEUKIN 10 AND CLINICAL FEATURES   
Interleukin 10 values and clinical features were analysed using Pearson’s Chi Square 
Test and the Significance was calculated  
The Asymp. Sig. and the linear to linear association has been depicted in Table 13 
Table: 12 
 
 
Value Degree of 
freedom 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 23.285 12 .025 
 
There was an significant association (p=0.025) between the IL categorization and the 
clinical features i.e. patients with Severe Dengue or Dengue with danger signs had 
significantly higher number of IL-10 levels. 
 
 
 
 
 
Table 11 
 CLINICALFEATURES Total 
1 2 3 4 
I
L
C
A
T 
NEG  1 0 0 0 1 
LESS THAN 10  8 4 0 0 12 
LESS THAN 50  14 6 7 1 28 
LESS THAN 100  4 3 6 2 15 
GREATER THAN 
100 
 
3 5 10 6 24 
Total  30 18 23 9 80 
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5.3.2  VALIDITY OF IL-10 ELISA IN SEVERE DENGUE  
Sensitivity of IL-10 ELISA =  
IL10 values more than 10 in patients with clinical feature score of 3 and 4  
Total number of cases with clinical feature score of 3 and 4 
= 100 % 
Specificity of IL-10 ELISA = 
IL10 values less than 10 in patients with score 1 and 2 
Total number of cases with clinical feature score of 1 and 2 
=27 % 
Positive Predictive Value = 
IL10 values more than 10 in patients with clinical feature score of 3 and 4 
Total number of patients with IL10 values more than 10 
=83.58% 
Negative Predictive Value = 
IL10 values less than 10 in patients with score 1 and 2 
Total number of patients with IL 10 values less than 10 
= 100% 
5.4 EVALUATION OF TNF-ALPHA ELISA FOR PROGNOSIS IN 
DENGUE PATIENTS 
The TNF Alpha values were graded as follows (based on the study by ozar et al. there 
was an arbitrary score given for grading TNF alpha values) 
Table 13 
 
S.NO VALUES INTERPRETATION 
1 0 Negative 
2 0-50 Moderately high 
4 51-100 High 
5 >100 Very high 
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The frequency of TNF alpha values in patients is depicted in Table 15 
Table 14 
 Percent 
Valid 
neg 17.5 
less than 50 50.0 
less than 100 15.0 
more than 100 17.5 
Total 100.0 
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5.4.1 CORRELATION BETWEEN TNF ALPHA AND CLINICAL FEATURES 
 
Table 15 
 
 CLINICALFEATURES Total 
1 2 3 4 
TNFalpha 
Negative  10 1 2 1 14 
less than 50  17 9 11 3 40 
less than 100  2 4 4 2 12 
more than 100  1 4 6 3 14 
Total  30 18 23 9 80 
 
 
The correlation between TNFalpha and clinical features was calculated using pearsons 
chi-square test 
The Asymp. Sig. and the Linear to Linear Association has been depicted in Table 16 
Table 16 
 Value Degree of 
freedom 
Asymp. Sig. (2-
sided) 
Pearson Chi-Square 16.126 9 .064 
 
 
The above table reveals there was no significant association between the TNF and the 
clinical features 
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5.4.2  VALIDITY OF TNF-alpha ELISA IN SEVERE DENGUE  
 
Sensitivity of TNF alpha ELISA =  
TNF alpha values more than 10 in patients with clinical feature score of 3 and 4  
Total number of cases with clinical feature score of 3 and 4 
= 85.29 % 
Specificity of TNF alpha ELISA = 
TNF alpha values less than 10 in patients with score 1 and 2 
Total number of cases with clinical feature score of 1 and 2 
=22.91 % 
Positive Predictive Value = 
TNF alpha values more than 10 in patients with clinical feature score of 3 and 4 
Total number of patients with TNF alpha values more than 10 
=45.31% 
Negative Predictive Value = 
TNF alpha values less than 10 in patients with score 1 and 2 
Total number of patients with TNF alpha values less than 10 
= 78.57% 
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5.4 EVALUATION OF IFN GAMMA ELISA FOR PROGNOSIS IN 
DENGUE PATIENTS 
The IFN gamma values were graded as follows (based on the study by ozar et al. there was an 
arbitrary score given for grading Interferon gamma values) 
Table 17 
 
S.NO VALUES INTERPRETATION 
1 0 Negative 
2 0-50 Moderately high 
4 51-100 High 
5 >100 Very high  
 
The frequency of IFN gamma values in patients is depicted in Table 18 
Table 18 
 Percent 
Valid 
neg 27.5 
less than 5 1.3 
less than 50 52.5 
less than 100 10.0 
more than 100 8.8 
Total 100.0 
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5.4.1 CORRELATION BETWEEN TNF ALPHA AND CLINICAL FEATURES 
The correlation was analysed using Pearson’s Chi Square test and has been presented in 
Table 20 
 
Table 19 
 CLINICALFEATURES Total 
1 2 3 4 
INF 
neg  17 4 0 1 22 
less than 5  0 0 1 0 1 
less than 50  11 11 16 4 42 
less than 100  2 2 2 2 8 
more than 100  0 1 4 2 7 
Total  30 18 23 9 80 
 
 
Table 20 
 
 
 
 
Value Degree of 
freedom 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 30.622 12 .002 
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There was an significant association (p=0.025) between the Interferon categorization 
and the clinical features i.e. patients with Severe Dengue or Dengue with danger signs had 
significantly higher number of IFN-gamma levels. 
5.4.2  VALIDITY OF IFN gamma ELISA IN SEVERE DENGUE  
 
Sensitivity of IFN gamma ELISA =  
IFN gamma values more than 5 in patients with clinical feature score of 3 and 4  
Total number of cases with clinical feature score of 3 and 4 
= 93.75 % 
Specificity of IFN gamma ELISA = 
IFN gamma values less than 5 in patients with score 1 and 2 
Total number of cases with clinical feature score of 1 and 2 
=91.30 % 
Positive Predictive Value = 
IFN gamma values more than 5 in patients with clinical feature score of 3 and 4 
Total number of patients with IFN gamma values more than 5 
=52.61% 
 
Negative Predictive Value = 
IFN gamma values less than 5 in patients with score 1 and 2 
Total number of patients with IFN gamma values less than 5 
= 43.75% 
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5.6 CUMMULATIVE CORRELATION OF ALL PARAMETERS 
The correlation between all the factors were calculated using Spearman’s Rho test  
 
The  table interprets there was correlation between the clinical features and platelet count, IL 
10 count, TNF alpha except the IFN gamma 
 
TABLE 21 
 
We can clearly see that the given values are the correlation coefficient between the 
various variables. Because mechanisms functioning behind the rise of various cytokines is 
different , their linear correlation was not calculated. However , their correlation with the 
clinical features and the platelet count was computed. In case of IL10 the correlation 
 CLINICALFE
ATURES 
PLATELETCO
UNT 
IL10pg
ml 
TNFALPHA
pgml 
INFGAMMA
pgml 
 
CLINIC
AL 
FEATUR
ES 
 
 
 
PLATEL
ET 
COUNT 
 
 
IL 10 
 
 
TNF 
ALPHA 
 
 
IFN 
GAMM
A 
 
Sig. 
(2-
tailed) 
. .004 .000 .001 .207 
N 80 80 79 66 58 
Sig. 
(2-
tailed) 
.004 . .093 .109 .766 
N 80 80 79 66 58 
Sig. 
(2-
tailed) 
.000 .093 . .561 .078 
N 79 79 79 65 57 
Sig. 
(2-
tailed) 
.001 .109 .561 . .473 
N 66 66 65 66 53 
Sig. 
(2-
tailed) 
.207 .766 .078 .473 . 
N 
58 58 57 53 58 
**. Correlation is significant at the 0.01 level (2-tailed). 
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coefficient is less than 0.01( 0.004)so it is positively correlated with both platelet count as 
well as clinical severity, similiarly for TNF alpha       ( 0.001) but it does not hold true for 
IFN gamma (0.207) 
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DISCUSSION 
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SOCIODEMOGRAPHIC PARAMETERS 
Immunity to dengue virus (DENV)is serotype-specific and long term. However, 
secondary infection by a heterologous serotype is a pre-disposing factor for severe disease. 
This was attributed to the phenomenon of ‘original antigenic sin’. 
Primary dengue infection occurs when a person is infected with dengue virus for the 
first time with any one serotype. Months to years later, a more severe form of dengue illness 
may appear (called secondary dengue infection) due to infection with another serotype which 
is different from the first serotype causing primary infection.  
Antibody response against Dengue virus – infection with dengue virus induces the 
production of both neutralizing and non neutralizing antibodies. The neutralizing antibodies 
are protective in nature. Such antibodies are produced against the infective serotype (which 
last lifelong) as well as against other serotype(which last for sometime). Hence, protection to 
infective serotype stays lifelong but cross protection to other serotypes diminishes over few 
months. 
The non neutralizing antibodies last lifelong and are heterotypic in nature ie. They are 
produced against other serotypes but not against the infective serotype. Such antibodies 
produced following the first serotype infection can bind to a second serotype, but instead of 
neutralizing the second serotype, it protects it from host immune system by inhibiting the 
bystander B cell activation antigen against the second serotype. The above phenomenon is 
called Antibody Dependent Enhancement which explains the reason behind the severity of 
secondary dengue infection. Being suboptimal in specificity and function, they fail to control 
infection and, instead, contribute greatly to a ‘cytokine storm’. 
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6.1 CORRELATION OF DEMOGRAPHIC PARAMETERS WITH SEVERE 
DENGUE 
Table 1 and 2 depict the age and gender distribution of the study. There were 34 
pediatric and 45 adult patients included in the study. The male and female patients included 
in the study were equal.  
As stated by Deen J et al and WHO definitions for Dengue 2009 severe dengue has 
been classified as dengue with warning signs and dengue without warning signs. This criteria 
was used to score the patients under four categories respectively which has been presented in 
table 3.  
Patients with a score of 1 and 2 showed signs and symptoms of dengue fever and were 
considered as Dengue without warning signs , however the ones with a score of 3 and 4 were 
the ones with danger signs and likely cases of severe dengue. 
The frequency distribution of these features (Table 4) showed that most patients who 
tested positive for Dengue remained asymptomatic or had vague manifestations. This was 
found in around 37 percent of the cases. The common presenting symptom in patients with 
severe dengue were bleeding manifestations  ; which was found in around one third of the 
total cases. Patients with moderate dengue most commonly presented with typical features of 
pedal oedema,  abdominal bloating etc. which could be likely due to low platelet counts 
accounting to the beginning of capillary leakage and associated pathology. A few cases also 
progressed to shock or DSS (Dengue Shock Syndrome) and Encephalitis; these being the 
hallmarks of severe Dengue. Lei hi et al has also stated in his study that platelet damage 
caused by antibodies produced against DENV during the ADE leads to these symptoms. 
Similar results were found in a study done by Priyadarshini et al. in North India where 
based on clinical features, 71.9% (n=159) of the patients were classified as DF, 50% of them 
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had thrombocytopenia without any bleeding. Presence of any two of the DHF defining 
criteria by WHO, categorized 62 patients as DHF cases. Seven patients were defined as 
severe DHF (grades III/IV) with signs of circulatory failure. One fatal patient had severe 
thrombocytopenia, plasma leakage and circulatory failure (Grade IV). Fever with chills, 
headache, myalgia and nausea/vomiting were reported equally by DF and DHF patients. Joint 
pain, retroorbital pain and itching were observed in a significantly larger number of DF cases 
(p,0.05, x2 test). Abdominal pain, maculopapular rash/petechiae and conjunctival congestion 
were found to be more prevalent in DHF cases ( p,0.05, x2 test).  
The correlation of demographic parameters like age and gender were done using 
Pearson’s Chi Square test which has been presented in Tables 5- 7.  
The frequency of each score of clinical features in pediatric and adult population as 
depicted in table 5. There was not a significant difference seen between various scores and 
the age group they belonged to as it is clear in table 5.  
The correlation between age and clinical features was calculation using Pearsons’s 
Chi Square test. There was insignificant correlation between the two parameters; hence 
proving that age does not play any prognostic role in pathogenesis of severe dengue. This was 
also in correspondence to a similar study done by Priyadarshini et al. 
A similar correlation was calculated between gender and clinical features depicted in            
Table 7. The frequency of clinical features did not differ much in the two gender groups and 
the results were comparable. Similarly, when correlation using Chi Square was calculated (p 
<0.025) it was found to be insignificant showing there is possibly no significant correlation 
between gender and dengue prognosis. Similar results were depicted by Himanshu et al and 
Pandey et al in their respective studies.  
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CORRELATION BETWEEN PLATELET COUNT AND CLINICAL FEATURES  
Time and again it has been stated in various studies that the most severe complications 
following dengue fever are attributed due to plasma leakage occurring as a result of 
thrombocytopenia in patients with dengue. This is more severe in secondary dengue where 
non neutralizing antibodies are produced that lead to Antibody dependent Enhancement 
leading to antibodies against platelets leading to thrombocytopenia.  
The patients included in the study had platelet count ranging from 16000 to 100000 with a 
mean of 63000 .There was a significant correlation between the platelet count and the clinical 
features ie. 0.04 (p <0.05) (Table 8) . This has also been stated by Radhakrishna et al. in is 
study in a similar group of patients where the platelet counts were significantly decreased in 
patients with warning signs and moreover there was also a fall in the platelet count during the 
post febrile phase indicating a role of immune related mechanisms playing a 
pathophysiological role during the defervescence stage of dengue. 
CORRELATION BETWEEN IL10 AND CLINICAL FEATURES 
The IL10 values were graded based on their OD values (optical density) and these were 
compared with the respective standards to compute the value in pg/ml. The frequency of IL 
10 values has been presented in Table 9. Most dengue positive patients had IL 10 values 
above 50pg/ml/. In comparison to Pandey et al.’s study between cases(serologically tested 
positive for dengue IgM ) and controls (tested negative) ; the levels of serum IL10 values in 
control population was found below 10pg/ml. The number of such population in the study 
was one-fifth of all cases. 
The IL 10 levels were compared to clinical features and the correlation was computed by 
Pearson’s Chi Square test. The value of IL 10 in patients with severe dengue that is in the 
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patients with a score of 3 and 4 was significantly high. More than 70% of cases with clinical 
features of Dengue with warning signs had raised IL10 levels.  
However , it was found that there were around one third of cases where IL10 values 
were high when the patient’s clinical score was 1 and 2 ie. Dengue without warning signs. 
These results were similar to those found by Pandey et al in their study where they 
have stated that levels of IL10 were signiﬁcantly increased in the presence of melena (a sign 
of gastrointestinal bleeding). High serum levels of anti-inﬂammatory cytokines such as IL-10 
were also found in DHF . Elevated levels of IL-10 in DHF patients compared to DF patients, 
reﬂecting an enhanced regulatory response to the more intense immune activation in DHF. 
The correlation between IL 10 and clinical features was calculated using Pearson’s 
Chi square test which showed a significant relation between the two. The asymp. Sig. was 
found to be 0.025 in the study.  
IL 10 estimation in patients of Dengue with warning signs showed a sensitivity of 
100% and a very high positive predictive value.  
In addition to the extrinsic ADE pathway, in which the Fcγ receptor directly facilitates 
DENV binding onto the cell surface for DENV infection/replication, an intrinsic ADE 
pathway induces IL-10-mediated immunosuppression . For the intrinsic pathway, the ADE of 
DENV infection triggers IL-10 production through an immune complex associated with the 
Fcγ receptor to enhance the infection severity. In the presence of ADE, the Fcγ receptor can 
facilitate viral entry and trigger intracellular signaling. The generation of autoimmunity and 
ADE may cause concerns for vaccine development against DENV infection. Both viral 
particles acting through the extrinsic pathway and Fcγ receptor signaling through the intrinsic 
pathway are important for IL-10 induction. 
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   Studies done by tsung sung sai et al show that overall, higher levels of IL-10 were 
detected in DHF/DSS patients compared with DF patients, and this trend was observed for 
infants, children, and adults. The time-kinetic analysis showed increased levels of IL-10 from 
the onset of fever to defervescence, and viremia primarily occurs during fever in dengue 
patients The relationship between IL-10 and viral replication is therefore speculated, and the 
possible pathogen effects may result from the IL-10-mediated inhibition of the antiviral IFN 
response. Maximal plasma IL-10 levels measured from the acute phase of infection correlated 
with the degree of plasma leakage, as determined by the pleural effusion index . Thus, IL-10 
may cause lymphocyte dysfunction through the suppression of the T cell proliferative 
response to mitogens, which occurs in dengue patients during the early stages of infection. 
Furthermore, having thrombocytopenia, has been associated with the presence of IL-10. 
 There has also been association found between elevated liver enzymes which could 
contribute to severe symptoms in Dengue to raise IL 10 levels. 
  Moreover, studies done in the past (Tsun Ting Tsai et al. , Gathsaurie Neelika 
Malavige et al.) show that the level of IL-10 is higher in secondary DENV-infected patients 
than in primary DENV-infected patients. IL-10 induction is associated with severe DENV 
infection and is a potential biomarker for acute DENV infection. Specifically, IL-10 
expression acts as predictive marker of death for DHF patient . 
With such a high sensitivity IL10 assay can prove to be an important screening 
marker for prognosis of Dengue Fever patients progressing to Severe Dengue. 
CORRELATION BETWEEN TNF ALPHA AND CLINICAL FEATURES   
Like IL10 ; serum TNF alpha values obtained by ELISA were graded as negative, 
moderately high, high and very high as depicted in Table 13. 
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Table 14 shows the frequency of TNF alpha values in pg/ml. More than 50% of the 
patients had TNF alpha values less than 50. N. Houghton-Trivin ˜o et al. stated in his study 
that DHF patient sera induced a significant increase in ICAM-1 expression compared with 
sera from DF patients and controls, and pre-treatment of the sera with a TNF-a neutralizing 
antibody inhibited almost 70% of ICAM-1 expression. This could likely be the cause of 
moderate elevation of TNF alpha values in Dengue positive patients. 
Furthermore, we measured the correlation between TNF alpha values and clinical 
features of the patients. Around 50% of the patients with dengue without warning signs had 
TNF alpha values higher than 50. Similarly only less than one fifth of the total population 
with severe dengue had higher TNF alpha values. This could probably be due to the negative 
association of TNF alpha with Dengue.  
The correlation between TNF alpha values and clinical features was calculated which 
interestingly showed no significant correlation between the two parameters.  
Moreover , an interesting finding on correlating platelet count with TNF alpha values 
was that there was a positive correlation between the two. This has been depicted in Table 21 
where a cumulative correlation between all the three interleukins , clinical features and 
platelet count has been deciphered using Spearman’s rho test. Now, this could be due to 
enhanced plasma leakage caused by TNF alpha which inturn leads to thrombocytopenia.      
In totality, TNF alpha levels are increased only in those Severe dengue patients who show 
marked plasma leakage and not in the ones who do not present with symptoms due to 
thrombocytopenia which explains why negative correlation when compared alone with 
clinical features and a significant correlation on cumulative comparison. 
Cardier et al., 2005; Green & Rothman, 2006 et al have also stated that sera from 
DHF patients induced marked activation in HUVECs, partly due to the effect of TNF-alpha , 
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a proinflammatory cytokine previously reported to be present during DENV infection. It also 
resulted in a significant increase in sST2 expression. Such data strongly indicate that TNF-
alpha is important for sST2 expression in endothelial cells. 
Recombinant sST2 also suppresses proinflammatory cytokine production following 
stimulation with LPS in macrophages and monocytes. It also promotes reduced TLR-4 
expression and IkB degradation (Sweet et al., 2001; Takezako et al., 2006). Administering  
sST2 to mice after intestinal ischaemia results in reduced TNF-alpha production and 
inhibition of vascular permeability, neutrophilia and haemorrhagia in the intestine and lungs 
(Fagundes et al., 2007).  
However, the sensitivity of TNF alpha was around 83 % ; the test also had a high 
negative predictive value of around 78%. 
CORRELATION BETWEEN IFN GAMMA AND CLINICAL FEATURES   
We graded interferon gamma values in a similar way as other two parameters into 
negative, moderately high, high and very high. 
The frequencies of interferons were tabulated(Table 19) and it was found that around 
one third of the patients who tested positive for dengue were negative for interferon gamma ; 
but , interestingly; a vast majority of patients ie. around 52% had interferon values between 5 
to 50. The moderate increase in the interferon gamma values can be attributed to the fact that 
interferon gamma is not activated by the virus directly rather by mitogens and vastly affects 
the nitric oxide synthatase pathways. 
Table 20 depicts the frequency of interferon value with various clinical feature 
scores. It is clear that more than 90 percent of patients with severe dengue ie. dengue with 
warning signs have raised interferon values ; thus making it a reliable prognostic marker for 
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severe dengue. Similar results were found by Pal et al.as well as many other previous studies 
where interferon values in severe dengue patients were markedly higher than control patients 
. 
Also, there were only 3 patients who had higher interferon values even without 
symptoms of severe dengue. With a Asymp. Sig of .002 there was a strong correlation 
between interferon gamma and clinical feature score of the patients. (p<0.025).  
Previous virological and clinical studies showed contribution of high virus replication 
and low viral clearance from the patient’s body leading to disease severity during DENV 
infection. In the last few years , several attempts have been made to identify interferon 
gamma as a serum marker , an adaptive immune cytokine to predict severe dengue. As 
increased IFN-gamma has been related to diminished viral clearance from the host, disease 
severity might also be related to its serum level. 
Dengue viral replication within the patient body has to face powerful host immune 
responses induced by cytokines like interferon gamma.  During early periods of viral 
replication , IFN gamma produced by stimulated CD4+ and CD8+ T cells, induces nitric 
oxide synthatase2 generation, which thereby enhances host immunity that plays an important 
role in virus replication control. 
Fagundes CT et al found that enhanced DENV replication was found in IFN gamma 
deficient mice with more severe disease manifestations like hematological alterations and 
hepatic injury. Replication of HCV, another member of the flaviviridae family, was also 
inhibited by IFN-gamma, which was associated with viral clearance within patient’s body. 
Therefore, low IFN gamma levels among patients without warning signs and high 
IFN levels in patients with warning signs in our study might have favored greater DENV 
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replication – thus exhibiting warning signs like persistent vomiting, , severe abdominal pain 
and clinical accumulation fluid.  
CUMMULATIVE CORRELATION AMONGST THE INTERLEUKINS, 
HAEMATOLOGICAL MARKERS AND CLINICAL FEATURES 
Table 20 depicts cumulative correlation between all the parameters included in the 
study. Using Spearman’s Rho test the correlation was computed and it was found that there 
was a significant correlation between platelet counts, clinical features, IL10 and TNF alpha 
but not with interferon gamma.  
This is in accordance with the mechanism of release of each of the cytokines as well 
as their site of action. As mentioned earlier , IL 10 is released due to ADE , which is also a 
key factor for antibodies against thrombocytes ; the two factors inturn cause an increase in 
IL10 values in dengue with warning signs and symptoms of thrombocytopenia .  
On the other hand TNF alpha mainly plays a role in vascular permeability and shows 
a positive association in patients of severe dengue with marked thrombocytopenia. 
As a matter of fact IFN does not show correlation when analysed with both clinical 
features and platelet counts. Also , as it has a separate mechanism of action than other viral 
related cytokines it does not show significant correlation with these. 
Thus, IL 10 has a direct correlation with both clinical features and thrombocytopenia 
making it a highly sensitive marker in case of severe dengue; TNF alpha values are raised in 
patients with thrombocytopenia only and IFN gamma correlates with the severity of Clinical 
features.  
 
 
95 
 
 
  
SUMMARY  
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The study was performed at Tirunelveli Medical College, Palayamkottai, Tirunelveli 
District from March to June 2017 to assess the pathophysiologic and prognostic role of 
proinflammatory and regulatory cytokines in Dengue Fever. 
 A total of 80 samples were collected out of which 34 were from pediatric patients and 
46 from adult patients. There were equal numbers of males and females ie. 40 each . 
 The samples were then tested for Dengue NS1 antigen and IgM ELISA; the ones 
tested positive were included. Furthermore , only those samples with a platelet count 
of less than 1,00, 000 were analysed further. 
 The samples were then analysed using ELISA for IL10, TNF alpha and IFN gamma 
levels in the serum. 
 The clinical features were also scored according to the WHO criteria of Dengue with 
warning signs and Dengue without Warning signs. 
 There was insignificant correlation between age, clinical features and gender. 
 The mean platelet count was 63000 and there was a positive correlation between 
platelet counts and clinical features. 
 There was a significant correlation between IL10 and clinical features. The sensitivity 
was found to be 100% 
 There was no significant correlation between TNFalpha and clinical features but the 
sensitivity was found to be 83%.  
 IFN gamma had a positive correlation with the clinical features. The sensitivity was 
93% and specificity was 91%. 
 A cumulative correlation was calculated and there was a positive correlation between 
clinical features, platelet counts, IL10 and TNF alpha but not with IFN gamma. 
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CONCLUSION 
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Early diagnosis and interventional measures can play a vital role in Dengue prognosis 
and can also prevent the patient from landing into Dengue Haemorrhagic Fever or Dengue 
Shock Syndrome. Moreover an insight into the Prognostic markers of Dengue can also help 
in early detection of Dengue with Warning Signs. 
The present study clearly indicates that IL10 is a highly sensitive marker of Severe 
Dengue and can be used as a screening tool in Secondary Dengue patients or those with 
warning signs. TNF alpha as it correlates strongly with patients with warning signs can be 
used for prognosis is patients presenting with symptoms. However interferon gamma 
correlates strongly with low platelet counts and can be a measure to screen patients 
presenting with fever with thrombocytopenia. 
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APPENDIX 
 
 
 
 
MASTER CHART 
S.No. AGE GENDER 
IP 
NUMBER 
PLATELET 
COUNT C.F.SCORE 
IL-10 
(pg/ml) 
TNF 
ALPHApg/ml) 
INF-
GAMMA(pg/ml) 
1 15 MALE 50332 70000 1 39.7 18.89 8.18 
2 60 MALE 47130 20000 1 90.8 14.64 12.5 
3 11 MALE 50550 100000 1 107.8 20.18 14.07 
4 14 FEMALE 51196 90000 1 172.3 22.92 99.9 
5 8 MALE 62847 85000 1 11.14 34.63 neg 
6 18 MALE 61793 24000 3 112 22.04 32.11 
7 27 FEMALE 62626 28000 1 64.98 22.04 9.96 
8 14 MALE 61050 38000 3 211 47.22 23.75 
9 15 MALE 63508 58000 2 55.35 47.22 6.52 
10 7 MALE 60539 90000 4 94.97 48.25 7.41 
11 32 FEMALE 49311 41000 3 72.34 15.74 67.94 
12 62 MALE 48893 86000 4 227.38 13.91 75.71 
13 2 MALE 51099 93000 1 221.23 NEG 75 
14 16 FEMALE 46102 70000 1 19.72 13.16 5.6 
15 6 FEMALE 62422 100000 2 7.31 16.28 NEG 
16 3 FEMALE 60133 100000 1 35.13 99.8 NEG 
17 18 MALE 61571 40000 1 9.57 17.02 NEG 
18 13 MALE 60708 31000 3 91.58 17.02 42.34 
19 26 FEMALE 60322 100000 1 NEG 56.16 11.13 
20 12 FEMALE 60122 17000 2 32.6 496.97 18.55 
21 13 MALE 17591 60000 2 104.2 31.48 15.72 
22 17 MALE 57076 37000 3 100 NEG 8.56 
23 9 MALE 50337 96000 1 49.3 16.43 NEG 
24 4 FEMALE 49542 77000 1 12.45 NEG NEG 
25 1.5 FEMALE 62754 100000 1 10.38 18.73 NEG 
26 12 FEMALE 60531 70000 3 32.5 63.12 44.35 
27 23 FEMALE 62484 45000 2 193.35 37.78 12.69 
28 14 MALE 61983 45000 3 153.69 16.183 17.07 
29 32 FEMALE 30195 23000 4 107.04 NEG NEG 
30 8 MALE 60059 70000 4 133.19 129.09 6.02 
31 25 FEMALE 50034 90000 1 96.42 14.54 9.6 
32 45 MALE 48628 38000 1 84.64 NEG 10.9 
33 9 FEMALE 50347 74000 3 24.14 215.45 4.9 
34 9 MALE 62921 100000 1 9.59 NEG NEG 
35 7 MALE 60359 40000 1 8.54 N EG NEG 
36 25 FEMALE 63431 45000 3 13.23 77.45 19.73 
37 18 MALE 63451 36000 1 7.76 34.28 NEG 
38 13 MALE 62756 80000 3 220.31 30.85 30.81 
39 7 MALE 61257 54000 2 34.39 70.84 7.44 
40 1 MALE 49738 100000 1 10.1 18.8 NEG 
41 13 MALE 48914 45000 3 92.23 NEG 6.23 
         
 
 
 
 
S.No. AGE GENDER 
IP 
NUMBER 
PLATELET 
COUNT C.F.SCORE 
IL-10 
(pg/ml) 
TNF 
ALPHApg/ml) 
INF-
GAMMA(pg/ml) 
42 18 MALE 49617 98000 3 423 130 435 
43 4 FEMALE 46934 89000 3 23.435 119.9 32.24 
44 17 MALE 50131 90000 1 36.27 NEG NEG 
45 1 FEMALE 61545 51000 1 8.23 122.76 NEG 
46 40 FEMALE 61135 98000 1 13.23 NEG 10.9 
47 11 MALE 67416 90000 2 7.76 NEG NEG 
48 22 FEMALE 63494 80000 3 77 94.4 19.3 
49 18 MALE 61643 41000 3 89.9 45.3 52.4 
50 33 MALE 61765 16000 2 39.5 23.14 54.5 
51 15 FEMALE 50848 60000 2 236 70 6.014 
52 5 FEMALE 51130 40000 3 31.77 42.569 8.3 
53 6 MALE 48722 95000 3 13.5 119.2 18.94 
54 22 FEMALE 48549 55000 4 176.76 83.06 8.29 
55 6 FEMALE 61832 92000 4 43.45 17.726 8.6 
56 8 FEMALE 59951 90000 2 24.17 53.52 NEG 
57 8 MALE 62500 40000 4 544 165.26 233 
58 15 FEMALE 67652 76000 3 363.1 31.456 7.3 
59 21 FEMALE 63665 44000 3 542 43.4 22.022 
60 31 FEMALE 61645 40000 2 8.48 102.95 25.46 
61 32 FEMALE 50934 23000 2 9.36 39.25 8.8 
62 6 FEMALE 50368 97000 1 33.14 NEG NEG 
63 2 FEMALE 47441 98000 2 58.95 16.057 12.24 
64 2 MALE 63257 90000 2 68.34 124.87 5.65 
65 3 MALE 61451 73000 2 24.27 66.12 103.51 
66 5 MALE 60115 58000 1 38.11 31.23 NEG 
67 10 FEMALE 61443 61000 4 80.77 51.33 103.3 
68 15 FEMALE 62973 98000 2 211 15.68 39.45 
69 18 MALE 61571 31000 4 564 173.17 63.3 
70 23 MALE 63070 85000 2 114 15.47 NEG 
71 13 FEMALE 48410 76000 3 40.9 40.1 131.25 
72 4 FEMALE 49733 88000 1 26.83 34.63 44.23 
73 5 FEMALE 51162 94000 1 33.86 NEG NEG 
74 3 MALE 62748 70000 2 39.6 156.48 72.62 
75 28 FEMALE 60959 62000 3 350 99 119.76 
76 34 FEMALE 61020 99000 1 8.69 13.57 NEG 
77 16 FEMALE 61021 36000 3 125.98 114.42 39.71 
78 28 MALE 62949 58000 1 12.46 NEG NEG 
79 17 MALE 63010 30000 3 309 119 112.62 
80 13 FEMALE 61775 90000 1 36.49 15.43 25.94 
                  
 
 
 
 
 
 
 
ABBREVIATIONS 
 
HUVEC- Human Umblical Vein Epithelial Cell 
DHF- Dengue Haemorrhagic Fever 
DSS- Dengue Shock Syndrome 
DwoWs- Dengue Without Warning Sign 
DWWS- Dengue With Warning Sign 
DC-SIGN- Dendritic Cell Specific Intercellular adhesion molecule 3 Grabbing Non Integrin 
JAK- Janus Kinase 
TAP- Tapasin 
CTLA- Cytotoxic T Lymphocyte Associated Protein 
Treg- T Regulatory Cell 
FoxP3- Forkheadbox P3 
ICAM- Intercellular Adhesion Molecule 
RANTES- Regulated on Activation Normal Tcell Expressed and Secreted 
PDGF- Platelet Derived Growth Factor 
CCL5- c-c motif Ligand 5 
VEGF- Vascular Endothilial Growth Factor  
MEK- Mitogen Activated Protein kinase 
ERK- Extracellular Signal Regulation Kinases 
PK- Protein Kinase 
MCP- Monocyte Chemoattractant 
 
 
 
 
 
CLINICAL PROFORMA 
PROFORMA 
Name : B/O Mrs. :                                                                          IP No.: 
Age :      days 
Sex : 
Address : 
Relevant clinical history 
Warning Signs – YES/NO 
Investigation 
Lab. No. : 
Platelet count : 
Dengue NS1 : 
Dengue IgM : 
IL 10 Result :           concentration: 
TNF alpha Result :                                               concentration: 
IFN gamma Result :         concentration: 
Outcome :  Recovery and discharge/ death 
 
